Introduction {#s1}
============

Neurons use local translation as a means of rapid, spatially restricted protein regulation in their distal processes, particularly during remodeling driven by external cues ([@bib10]; [@bib61]; [@bib19]). Memory consolidation requires new proteins to stabilize molecular changes induced by learning ([@bib9]; [@bib32]), and local translation in dendrites is thought to be an essential source of these proteins ([@bib54]). Rich and diverse assortments of mRNAs have been described in neuropil of the mature hippocampus ([@bib40]; [@bib69]; [@bib6]) and in cortical synaptoneurosomes ([@bib39]), underscoring the importance of decentralized translation in synaptic function. Yet no role for axonal translation in learning and memory has been reported in the adult forebrain.

Translation has long been known to occur in invertebrate axons, and it is now established to be essential for growth and response to guidance cues in developing CNS axons, and in regeneration of PNS axons ([@bib1]; [@bib59]; [@bib25]; [@bib3]). Adult forebrain axons, in contrast, traditionally have been characterized as lacking the capacity for translation, in part due to a lack of reliable evidence, and in part to the perception that they are structurally and functionally inert compared to dendrites and immature axons ([@bib28]; [@bib25]; [@bib3]). However, a number of recent studies have shown that mature axons are in fact capable of translation, at least in some circumstances ([@bib64]; [@bib15]; [@bib26]), including in the CNS ([@bib55]; [@bib2]; [@bib27]; [@bib51]; [@bib16]). This work has largely been done with cultured neurons, but one study used translating ribosome affinity purification (TRAP) to isolate ribosome-bound mRNAs in retinal ganglion cells (RGCs) of adult mice ([@bib51]), demonstrating that ribosome-bound mRNAs are present in adult CNS axons in vivo. Presynaptic translation has been shown to be necessary for long-term depression in hippocampal ([@bib67]) and striatal ([@bib66]) slice preparations from young animals, indicating that axonal translation is involved in synaptic plasticity and therefore could be important in memory as well.

Aversive auditory Pavlovian conditioning (fear or threat conditioning), in which animals learn to associate an auditory tone with a foot shock, is supported by persistent strengthening of synaptic inputs to the lateral amygdala (LA) from auditory areas ([@bib24]). The LA receives strong excitatory input from auditory cortical area TE3 ([@bib43]; [@bib50]; [@bib11]), and Pavlovian conditioning induces persistent enhancement of presynaptic function at these synapses ([@bib33]; [@bib58]; [@bib22]; [@bib47]). Consolidation of memory requires translation in the LA ([@bib45]), and we have found that it induces changes in the translational machinery in LA dendrites associated with synapse enlargement ([@bib37]). Intriguingly, we also found that learning-induced structural changes occurred at individual axonal boutons as opposed to uniformly along axons, suggesting that plasticity may be as synapse-specific and compartmentalized on the presynaptic side as it is on the postsynaptic side ([@bib38]). To determine whether axonal translation is involved in memory formation, we confirmed the presence of translation machinery in LA axons, and combined TRAP with RNAseq to identify changes in the translatome of auditory cortical axons during memory consolidation.

Adult axons contain translation machinery {#s1-1}
-----------------------------------------

Early electron microscopy studies reported abundant polyribosomes in the somata and dendrites of neurons, but rarely in axons (reviewed by [@bib12] and [@bib25]). However, the paucity of conspicuous polyribosomes does not necessarily preclude translation. Regenerating sciatic nerve axons contain mRNAs and translate membrane proteins in vivo, but do not show ultrastructural evidence of polyribosomes or rough endoplasmic reticulum ([@bib68]; [@bib35]). In addition, hippocampal interneuron axons contain ribosomal proteins ([@bib67]). This suggests that translation sites other than the classic morphological structures do exist, such as the periaxoplasmic ribosomal plaques found in adult spinal cord axons ([@bib29]). Recent work in yeast has shown that translation can occur on 80S monosomes, with a bias toward highly regulated transcripts ([@bib18]).

We have occasionally observed polyribosomes in presynaptic boutons in the adult rat LA by EM ([Figure 1a--b](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1a--e](#fig1s1){ref-type="fig"}), although these are infrequent (LO, unpublished observations). A possible explanation for this is that these axons contain translation machinery that does not usually assemble into polyribosomal structures with traditionally recognizable morphology, such as monosomes, whose morphology is not distinctive enough for unequivocal identification. To more directly assess the potential for translation in LA axons, we used immuno-electron microscopy to localize components of the translation machinery. Because translation initiation is most extensively regulated step in gene expression, as well as a critical mediator of memory formation ([@bib44]), we focused on translation initiation factors. The eukaryotic initiation factors eIF4E, eIF4G, and eIF2α each were present in axons forming synapses onto spiny dendrites in the caudal dorsolateral subdivision of the LA ([Figure 1c--e](#fig1){ref-type="fig"}), which receives the most robust projections from TE3 ([@bib43]; [@bib50]; [@bib11]), as was ribosomal protein S6 ([Figure 1f](#fig1){ref-type="fig"}). These synapses have the same classic excitatory morphology as the glutamatergic projections from TE3 to LA ([@bib11]), consistent with local translation on TE3 inputs. Quantification of eIF4E immunolabel through serial sections of neuropil revealed that 63% of axons were labeled, along with 39% of dendritic spines and 100% of dendritic shafts ([Figure 1---figure supplement 1f--i](#fig1s1){ref-type="fig"}). Consistent with this pattern, we have previously found polyribosomes throughout dendritic shafts but in only a subset of dendritic spines, where their presence is regulated by learning ([@bib37]).

![Electron micrographs of translation machinery in lateral amygdala axons.\
(**a--b**) Polyribosomes (black arrows) in axonal boutons (asterisks). A polyribosome in an astrocytic process (white arrow) is visible at the lower left of panel (**a**). (**c--e**) Axonal boutons (asterisks) containing immunolabeling (black arrows) for eIF4E (**c**), eIF4G1 (**d**), and eIF2α (**e**). White arrowheads indicate asymmetric synapses onto dendritic spines (a, d, and e) and shafts (**b and c**). (**f**) Myelinated axon (asterisk) containing immunolabel for ribosomal protein s6 (arrow). Scale bars = 500 nm.](elife-51607-fig1){#fig1}

Isolation of the adult axonal translatome {#s1-2}
-----------------------------------------

To identify ribosome-bound mRNA transcripts in distal TE3 axons, we used TRAP ([@bib17]), in which a tagged ribosomal protein is expressed in cells of interest and used to immunoprecipitate ribosome-bound mRNA. A recent study used an HA-tagged ribosomal protein to examine the translatome of retinal ganglion cell axons in both immature and adult mice ([@bib51]), and an eGFP-tagged ribosomal protein expressed in adult mouse layer V cortical neurons was observed in axons of the corticospinal tract ([@bib60]), demonstrating that this method is viable in at least two types of adult CNS neurons in vivo. We used a viral vector to express an eYFP-ribosomal protein L10a fusion protein ([@bib30]) in TE3 cells in adult rats ([Figure 2a--b](#fig2){ref-type="fig"}). Pilot experiments using an adeno-associated viral vector resulted in moderate to strong retrograde infection of cells in afferent areas. To ensure that no cell bodies outside of the injection site expressed the construct, we switched to a lentiviral vector, which did not result in retrograde infection. Lentivirus has also been shown to have preferential tropism for excitatory neurons over inhibitory neurons in the cortex ([@bib36]), which is advantageous since TE3 projections to the amygdala are excitatory. Immuno-electron microscopy confirmed the presence of eYFP in LA axons ([Figure 2c--f](#fig2){ref-type="fig"}).

![Transport of a tagged ribosomal L10a protein to cortical projection axons.\
(**a**) Schematic of injection site in cortical area TE3 and its lateral amygdala (LA) projection area, with AP coordinates from Bregma noted. The black square indicates the area of LA sampled for EM. PRh: perirhinal cortex. (**b**) Immunolabeling of YFP in transfected TE3. (**c--f**) Electron micrographs of LA showing axonal boutons (asterisks) containing YFP immunolabel (black arrows). The boutons in (**e**) and (**f**) are forming asymmetric synapses (white arrowheads) on a dendritic spine head (**e**) and a dendritic shaft (**f**). Scale bars = 500 µm in (**b**) and 500 nm in (**c--f**).](elife-51607-fig2){#fig2}

TRAP was combined with Pavlovian conditioning to determine how the axonal translatome changes during memory consolidation ([Figure 3a](#fig3){ref-type="fig"}). Animals expressing eYFP-L10a in TE3 were given either Pavlovian conditioning, consisting of auditory tones paired with mild foot shocks in a familiar chamber (the trained group), or exposure to the chamber alone (the control group). We did not present unpaired tones and shocks to the control group because this paradigm constitutes a different type of associative learning and results in plasticity at LA synapses ([@bib42]; [@bib37]). Long-term memory formation requires de novo translation during a critical period of several hours after training ([@bib9]; [@bib45]), thus we sacrificed animals during this time window and collected separate tissue blocks containing either the auditory cortex or the amygdala ([Figure 3---figure supplement 1a](#fig3s1){ref-type="fig"}). Although we refer to these samples as cortex and axons, the cortex samples also contain the proximal axon segments, myelinated segments that pass through the dorsal portion of the external capsule, as well as intrinsic projections and corticocortical projections terminating in adjacent areas of TE1 and perirhinal cortex ([@bib43]; [@bib50]). We should also note that our use of the term 'translatome' refers simply to the set of mRNAs that are bound to ribosomes, and therefore past the initiation step of translation, but these transcripts are not necessarily undergoing active elongation or termination at the moment of capture.

![Isolation of the TE3 axonal translatome.\
(**a**) Experimental workflow (see text). (**b**) Principal component analysis of all experimental replicates. (**c**) Overlap between axonal and cortical translatomes. (**d**) Most enriched GO terms and KEGG pathways in axonal and cortex-only translatomes, sorted by Benjamini-Hochberg adjusted p-value. Gray X's indicate effects that were not significant (adjusted p-value\>0.05).](elife-51607-fig3){#fig3}

RNASeq was performed on the TRAPed mRNAs as well as the total mRNA isolated from the homogenized tissue blocks (the tissue transcriptome). Quality control metrics are shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Principal component analysis revealed correspondence between experimental replicates, as well as separation between the TRAPed samples and the transcriptome, the cortex and axons, and the trained and control groups ([Figure 3b](#fig3){ref-type="fig"}). Gene expression levels were correlated between replicates ([Figure 3---figure supplement 1b](#fig3s1){ref-type="fig"}). Differential gene expression (DGE) analysis was used to compare the eight groups (TRAPed mRNAs and the input tissue transcriptome from two brain areas of each of the two behavioral groups). Three types of comparisons were performed: TRAPed mRNAs were compared to the corresponding input tissue transcriptome, the axons and cortex were compared in each behavior group, and the behavior groups were compared in each brain area ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Comparison with a cell-type-specific proteome ([@bib48]) revealed that neuronal genes were more likely than non-neuronal genes to be enriched in the TRAPed samples versus the tissue transcriptome, whereas non-neuronal genes were more likely to be depleted ([Figure 3---figure supplement 1c](#fig3s1){ref-type="fig"}), confirming that our TRAPed samples contain mainly neuronal genes.

Because no translatome or transcriptome of adult forebrain axons has been previously published, we chose to take a conservative approach to defining axonal genes in our dataset ([Figure 3---figure supplement 2a](#fig3s2){ref-type="fig"}). In order to minimize false positives introduced by the TRAP procedure, only genes that were differentially expressed between TRAPed samples were included. Although this should account for much of the background from the experimental procedures, it does not account for differences between the background transcriptome of the tissue samples, and we therefore excluded genes that were differentially expressed in the corresponding tissue transcriptomes. Finally, genes that were differentially expressed between TRAPed samples were excluded if the enriched sample also was not enriched versus the tissue transcriptome. We defined genes that met these criteria as axonal if they were regulated by learning in the axons, enriched in the axons versus the cortex in either experimental group, or both. Examination of expression levels showed that our filtering method selected for more abundant genes with higher correlation between experimental replicates ([Figure 3---figure supplement 2b](#fig3s2){ref-type="fig"}). Of the 1482 axonal genes identified, the majority (1028) were also either regulated or enriched in the cortex ([Figure 3c](#fig3){ref-type="fig"}), and an additional 703 genes were regulated or enriched only in the cortex (defined as 'cortex-only' genes). It is important to note that although we are using the term 'translatome' to refer to the stringently selected subset of genes we used for analysis, the actual population of axonal mRNAs is almost certainly larger.

To directly assess the background introduced by the IP procedure, we repeated the TRAP experiment in animals that were not injected with the TRAP virus. In addition to the IP, mRNA binding to the overexpressed eYFP tag itself, as opposed to the tagged ribosomes, is another potential source of background. Instead of using an empty AAV backbone or a different reporter as a control, we used a lentivirus encoding eYFP to account for this possibility. As expected, there was substantial overlap between genes enriched in the TRAP and eYFP-IP samples versus the tissue transcriptome ([Figure 3---figure supplement 2c](#fig3s2){ref-type="fig"}). There were, however, very few learning-associated mRNAs in the eYFP-IP experiment, and these had little overlap with the TRAPed mRNAs, and even less after the filtering step. Although there was 47% overlap between axonal and cortical genes in the TRAP experiment ([Figure 3c](#fig3){ref-type="fig"}), there was only 2.5% overlap in the eYFP-IP experiment. These data confirm that the results of our TRAP experiment are not due to background. Because the eYFP-IP experiment targeted axonal eYFP, these samples were likely enriched for axonal mRNAs, ribosome-bound or not. Our data cannot distinguish these, but the background levels of extra-axonal mRNA in our dataset may be even lower than this control experiment indicates.

Composition of the axonal translatome {#s1-3}
-------------------------------------

To characterize the axonal translatome, we used DAVID ([@bib21]) (<https://david.ncifcrf.gov>, version 6.8) to identify Gene Ontology (GO) Terms and KEGG Pathways enriched in the axonal and cortex-only gene sets. Complete results of DAVID analyses are in [Supplementary file 4](#supp4){ref-type="supplementary-material"}. The most significantly enriched terms in axons related to mitochondria, translation, and neurodegenerative diseases, whereas cortex-only genes were enriched for terms associated with the cell body, nucleus, and dendrites ([Figure 3d](#fig3){ref-type="fig"}). To ensure that our filtering process did not dramatically skew the composition of the final dataset, we also analyzed the unfiltered set of axonal genes. The resulting list of terms was similar, although enrichment levels were lower, consistent with a lower signal-to-noise ratio in the unfiltered data ([Figure 3---figure supplement 3a](#fig3s3){ref-type="fig"}). Comparison between the filtered data from the TRAP and eYFP-IP experiments revealed little similarity between the most enriched GO terms ([Figure 3---figure supplement 3b](#fig3s3){ref-type="fig"}). Manual grouping of significantly enriched terms revealed that terms relating to the presynaptic compartment and cytoskeleton were also predominantly found in axons, along with terms relating to various other cellular functions such as the ubiquitin-proteasome pathway, GTPase signaling, and intracellular transport ([Figure 3---figure supplement 4a](#fig3s4){ref-type="fig"}).

The size and composition of the TE3 axonal translatome are similar to what has been reported in the translatomes of retinal ganglion cell axons ([@bib51]) and cortical synaptoneurosomes ([@bib39]), the transcriptome of adult hippocampal neuropil ([@bib40]; [@bib69]; [@bib6]), and the transcriptomes of axons isolated from cultures of dorsal root ganglion ([@bib64]; [@bib15]), cultured motor neurons ([@bib4]), and mixed cortical/hippocampal neurons ([@bib55]). We compared these datasets to our axonal and cortex-only translatomes and found greater overlap with the axonal genes, with 904 of the 1482 genes (60%) present in at least one published dataset ([Figure 3---figure supplement 4b](#fig3s4){ref-type="fig"}). Given that these data were obtained from different cell types, preparations, ages, and species, this suggests that at least some aspects of the axonal transcriptome are universal. In particular, transcripts associated with protein synthesis and energy metabolism are found throughout the various datasets. Interestingly, our axonal translatome had substantially more overlap with datasets from immature versus mature axons, potentially reflecting recapitulation of developmental mechanisms in learning.

Opposite changes after learning in axons and cortex {#s1-4}
---------------------------------------------------

The majority of genes in the translatome (1647 of 2185 or 75%) showed differential expression following learning, with 19% (415) and 6% (123) of the remainder enriched in the cortex or axons, respectively. Of regulated genes, 40% showed significant changes in both axons and cortex, and all but one of these (the mitochondrial enzyme *Dlst*) were regulated in opposite directions ([Figure 4a](#fig4){ref-type="fig"}). The magnitude of change in the axons and cortex was significantly correlated for these genes, particularly for those downregulated in axons and upregulated in cortex ([Figure 4b](#fig4){ref-type="fig"}). Expression levels in the axons and cortex were significantly correlated in both training groups regardless of learning effects, although genes that were upregulated in the axons showed the highest correlation ([Figure 4---figure supplement 1a--b](#fig4s1){ref-type="fig"}). In the control group, genes that were downregulated in axons showed the lowest correlation between the two areas, but this increased in the trained group, particularly for genes that were also upregulated in the cortex. These results suggest that the axonal translatome is not regulated independently, but that compartment-specific translation is coordinated within the cell. This is underscored by the fact that only 63 genes encompassed the 50 most abundant in both areas and conditions ([Figure 4---figure supplement 1c](#fig4s1){ref-type="fig"}). Genes that were upregulated in axons had the highest expression levels in both areas and conditions, further suggesting common regulatory mechanisms ([Figure 4c](#fig4){ref-type="fig"}). In contrast to the TRAP experiment, there was no overlap between the 115 genes regulated after learning in axons and the 21 regulated in cortex in the eYFP-IP experiment.

![Learning-associated changes in the axonal translatome.\
(**a**) Overlap of training effects in the axons and cortex. (**b**) Correlations between effect sizes in the axons and cortex for genes differentially expressed in both areas after learning (left) or only one area (right). Regression lines are shown for correlations significant at p\<1 × 10^−5^. (**c**) Mean expression levels of genes in each group with respect to training effects. Results of ANOVA and post hoc test are given in [Supplementary file 5](#supp5){ref-type="supplementary-material"}. Error bars = s.e.m. (**d**) Top GO term and KEGG pathways enriched \>3 fold in learning-regulated genes, ranked by Benjamini-Hochberg adjusted p-value. Highly redundant terms are not shown. (**e**) Top regulatory pathways affected by training in axons and cortex, sorted by adjusted p-value. Activation z-score represents the probability of a pathway being activated or inhibited after learning. (**f**) Overlap between genes up- or downregulated in axons by learning and published axonal translatomes and transcriptomes. \* Data from [@bib51]; \*\* Data from [@bib15], [@bib64], [@bib55], and [@bib4]. (**g**) For genes that had multiple transcripts and were regulated by training in both axons and cortex, the contribution of each transcript to the gene-level effects in axons and cortex were correlated for genes upregulated in axons and downregulated in cortex (left) and genes downregulated in axons and upregulated in cortex (right). The contribution score was calculated as (change in FPKM transcript)/(change in FPKM gene).](elife-51607-fig4){#fig4}

Performing DAVID analysis separately on upregulated and downregulated genes revealed that learning was associated with inverse, function-specific changes in the axonal and cortical translatomes ([Figure 4d](#fig4){ref-type="fig"}). To further explore the learning-associated changes in cellular functions, we used Ingenuity Pathway Analysis (IPA) software (Qiagen). IPA evaluates changes in gene expression with respect to a database of known pathways and functions, and assigns an enrichment p-value along with a z-score predicting activation or inhibition of a pathway based on published data. A search for upstream regulators found that most of the enriched pathways had opposite z-scores in the axons and cortex ([Figure 4e](#fig4){ref-type="fig"}, [Supplementary file 6](#supp6){ref-type="supplementary-material"}). Analysis of functional annotations with IPA similarly revealed opposing functional regulation in the two areas ([Figure 4---figure supplement 2a](#fig4s2){ref-type="fig"}, [Supplementary file 7](#supp7){ref-type="supplementary-material"}). Although the axonal transcriptome is theoretically a subset of the somatic transcriptome, these results demonstrate an unexpected degree of coordination between the axonal and cortical translatomes.

Learning-associated changes in the axonal translatome {#s1-5}
-----------------------------------------------------

Learning was associated with changes in genes related to a range of cellular processes, with some clear patterns of upregulation and downregulation. An overview of regulated genes is shown in [Table 1](#table1){ref-type="table"}. The genes upregulated in axons, along with those downregulated in cortex, were dominated by two functions: mitochondrial respiration and translation. Axons have high metabolic needs and abundant mitochondria, so it is unsurprising that enrichment of mitochondrial transcripts in axons has been reported by a number of studies ([@bib64]; [@bib55]; [@bib15]; [@bib51]). Overall, 24% of the transcripts upregulated in axons and 25% of those downregulated in cortex encoded mitochondrial proteins, most of which were involved in either respiration or translation ([Figure 4d](#fig4){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). A few mitochondrial genes were downregulated in axons, however, including some involved in regulation of mitochondrial fusion and localization, such as *Mfn1* and *Opa1*. The opposite pattern was reported in the transcriptome of cultured cortical neurons 2 days after injury: *Mfn1* was upregulated while transcripts related to respiration were downregulated ([@bib55]). If similar regulation occurs in the two paradigms, these results are consistent with translation of dormant axonal mRNAs in response to activity, leading to their upregulation in the translatome and subsequent depletion from the transcriptome.

###### Examples of genes found in auditory cortical axons during memory consolidation by function and effect of learning.

Genes in bold type were changed in the opposite direction in the cortex.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type                                 Upregulated in axons                                                                                                                                                                                                                                                                                                           Downregulated in axons                                                                                                                                                                                                       Enriched in axons,\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   not regulated
  ------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------
  Mitochondrial respiration            **Atp5(d,e,g1,g2,g3,h,i,j,j2,5l,5o)**,**Atp6v(if,**0b**, 1g1)**,**Cox(4l1,5a,5b,6a1,**6a2**,6c,7a2,7a2l,7b, 7 c,8a,17)**,Dlst,Mdh1,**Mpc(1,2)**,**Ndufa(2,4,5,6,7,11,12,b1)**,**Ndufb(2,3,4,**5**,6,7,**8**,9,10,11)**, **Ndufc2**,**Ndufs(4,5,6,**8),**Ndufv(**2,**3)**,**Suclg1**, **Uqcc2, Uqcr(10,11,b,**c2,**fs1,h,q)**   Aco2,**Atp5**(a1,**b**),Fh,**Got2,Idh(2,**3b), **Ndufa10**,**Ndufs(**1,**2**,3),**Ndufv1**,**Ogdhl**, **Pc,**Pck2,**Pdh(a1,**b),**Sucla2**                                                                                   Cox20,Me3,Uqcrc2

  Mitochondrial translation            **Mrp63**,**Mrpl(**11,12,13,16,**18,20**,23,27,**34**,35,**41**,44,51,52,**54,55**),**Mrps(7,11,12,14,15,16,18b, 18 c,21**,23, **25,26**,28,**33**,34,36)                                                                                                                                                                      Mrpl(19,37),Mtif2,Tufm                                                                                                                                                                                                       Mrpl16,Mrps9

  Mitochondrial, other                 **Fis1,Minos1,Timm(8b,10,13)**                                                                                                                                                                                                                                                                                                 Cluh,Immt,Mfn1,**Pink1**,Opa1                                                                                                                                                                                                Aldh2,Oxa1l,Sdhd

  Ribosomal proteins                   **Rpl(**3,4,5,6,7,8,9,**10,**10a,11,12,13,13a,14,15, **17**,18,18a,**19,21,22l1,23,**23a**,24,26,27,27a,28,** 29**,30,31,32,34,35,35a,36,**36a,37**,38,**39,**p1), Rps(**3**,3a,**4x,5**,7,8,**10,**11,12,13,14,**15,**15a,**16, **17,**\                                                                                      **Rps2**                                                                                                                                                                                                                     
                                       **18,21,**23**,24,25,**26**, 27,27a,28,**29**,a)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Translation apparatus/regulation     **Eef1(**a2,**b2**,d,e1),**Eif1b**,**Eif2s2**,Eif3g,Eif5b, **Erp29**,**Fkbp(2,**3),Hspa5,Naca,**Pfdn(**1**,2,5,6)**, Sil1, **Srp(9,**14,**19)**                                                                                                                                                                                Apc,**Cyfip(**1,**2)**,**Denr**,**Eef2**,Eif2b5, **Eif3(**a**,d)**,Eif3l,Eif4a1,Eif6,**Mtor,**Rps6kb2,**Tsc2**                                                                                                               Rheb,Rps6ka2

  Spliceosome                          Gemin7,**Hnrnp(**a1,**a2/b1**,**a3**,**d**,l,r,ul2),**Lsm(3,4,5,**7,8),Nono,**Sf3b(2,6)**,Sfpq,Smndc1,**Snrnp27,Snrp(**b2**,c,d2,e,f,g),Ssrf4**                                                                                                                                                                                Snrp200                                                                                                                                                                                                                      

  Golgi apparatus                      **Napg**,**Tmed9**,Trappc(3,5)                                                                                                                                                                                                                                                                                                 Copa,**Coro(1 c,7)**,Gbf1,Gorasp1,**Trappc (**9,**10,**11)                                                                                                                                                                   Copg2

  Transcription                        Brd(4,**7**),**Btf3**,Cited2,Ddit3,Dek,Dnajc2,**Drap1**,**Gtf2h5**,Hmgb1,Id4, **Lmo4**,**Morf4l1**,**Ncor(1,2)**, **Polr2(e,**f**,g,j,k)**,**Sub1**,Taf10                                                                                                                                                                      Apbb1,Ahctf1,Baz2b,Cnot8,**Gtf3c(1**,3), Mta1,**Nsmf**,**Polr2b**                                                                                                                                                            Baz1a,Hes6

  Proteasome/ubiquitination            Psm(a7,d4,d7,d12,g4),**Psmg4**, Ube2(k,v2)                                                                                                                                                                                                                                                                                     Elp2,**Psm(**a1,**a4**,a5,b3,**b4,c1,c5**,d1,d2),**Ube(**3a,3b,**4b),Ubr4**                                                                                                                                                  Psma6,Smurf1

  Active zone/synaptic vesicle cycle   Ap2s1,Bloc1s4,**Calm(1,2)**,**Clta**,Gabbr1,Gng13,Hspa8,**Lin7b**, **Marcks**,**Nos1ip**,**Nrgn,Pfn(**1**,3)**, **S100b**,**Stmn2**,Syt1,Unc13a                                                                                                                                                                                **Ap**(2a1,**2m1**,**3d1**),**Atp6v0a1**,**Brsk1**,**Bsn**,Btbd9,**Camk2a**,**Camkv**,Dnm1,Gna(12, b2,l1),**Gsn**,Nos1ap,Rab3a,**Scrib**, **Sptan1**, **Sptbn(1,2),Stxbp1**,Synj1,Vdac (1,2,3)                               Nos1,Pcdh17,Prkcg

  Cytoskeleton/axonal transport        **Bloc1s1**,**Dynll(1,2)**,**Dynlrb1**,**Klc1**, **Sod1**                                                                                                                                                                                                                                                                      Bicd2,**Clip1,Dctn1**,**Dync(1h1,**2h1),Hap1,Htt,**Kif(3a,**5a**,5b,5c,**c3**,ap3)**,**Myo(**1b,**1d, 5a**,5b,**9a**,9b,**16,18a)**,**Myh(10,14)**,**Nefh, Nefl,Nefm**,**Tuba(**1b,**4a)**,**Tubb(**2b,**3,4a**, 4b,**5)**   Llgl1,Myh11,Myo10, Tubb2a,Tubg1

  Myelin sheath                                                                                                                                                                                                                                                                                                                                                       Ank3,Cnp,Cntnap1,**Mbp**,**Sptnb4**                                                                                                                                                                                          Myrf

  Postsynaptic                                                                                                                                                                                                                                                                                                                                                        **Dbn1**,**Ddn**,**Dlgap(1,3,4)**,Mink1,**Ppp1r9 (a,b)**,**Shank(1,2,3)**                                                                                                                                                    

  Other axonal/signaling               Akap5,Akip1,Eno1,**Gap43**,Mapt,**Olfm1,Park7, Sumo2,Tmsb4x**                                                                                                                                                                                                                                                                  **Akap(2,**6**,8 l,11,**13),Aldoc,**Arhgap(21,** 39),**Arhgef(2,**11),**Dpysl2**,Fez1,**Kalrn**, Rab(2b,3b,3c, 5 c,6b),Rock2,Vim                                                                                             Arhgap26,Arhgef(12,18,28)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Genes coding for translation-related functions, from mRNA splicing to protein folding, were also largely upregulated in axons and downregulated in cortex. Of 68 axonal transcripts encoding ribosomal proteins, 67 were upregulated after learning and 37 of these were downregulated in the cortex. The axonal translatome contained spliceosome components, nearly all of which were upregulated. Genes for initiation and elongation factors were mostly upregulated, although some were downregulated. Intriguingly, a number of genes encoding transcription factors were regulated in axons. Transcription factors are translated locally in growth cones and transported retrogradely to the nucleus (see [@bib23] for review), so this could be a case of developmental mechanisms supporting learning in the adult.

A number of transcripts encoding Golgi and rough ER proteins were present in the axonal translatome, although neither of these structures are seen in adult forebrain axons by EM. Similar observations have been reported in axons of cultured neurons, which carry out Golgi and rough ER functions in the absence of classical structures ([@bib63]; [@bib34]; [@bib13]). Rough ER proteins tended to be upregulated, whereas Golgi proteins were both upregulated and downregulated. Several upstream regulators of translation were downregulated in axons, including *Apc*, *Cyfip1*, *Mtor*, and *Tsc2*. Because mTOR complex 1 (mTORC1) activates translation of ribosomal proteins and translation factors ([@bib20]; [@bib57]; [@bib56]), one possibility is that *Mtor* mRNA was depleted from axons in an initial wave of learning-associated translation, leading to upregulated translation of downstream targets at the time the tissue was collected. Consistent with this, IPA analysis indicated activation of mTOR in the axons ([Figure 4e](#fig4){ref-type="fig"}).

Mitochondrial and ribosomal genes made up half of the most highly expressed genes ([Figure 3---figure supplement 3c](#fig3s3){ref-type="fig"}), which could account for the high average expression level of upregulated axonal genes ([Figure 4](#fig4){ref-type="fig"}). However, removing these genes did not substantially lower the mean expression levels ([Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}), indicating that high expression is a feature of upregulated genes independent of function.

Genes downregulated in axons encoded more diverse types of proteins than upregulated genes. These included cytoskeletal components and molecular motors, including tubulins, myosins, dyneins, kinesins, and neurofilaments ([Figure 4d](#fig4){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). Genes encoding synaptic proteins, including synaptic vesicle cycle, active zone, and postsynaptic density proteins, were downregulated, as were signaling molecules and components of the ubiquitin/proteasome pathway and myelin sheath. We used DAVID to examine the 25% of genes in our dataset that were not associated with learning to determine if there were any functions specific to these genes, but found only one term, 'mitochondrion,' enriched in axonal genes, and terms relating to the somatodendritic compartment enriched in the cortex ([Figure 3---figure supplement 4a](#fig3s4){ref-type="fig"}).

We compared the learning-associated genes to published translatomes of in vivo RGC axons ([@bib51]) and transcriptomes of cultured DRG and cortical axons ([@bib64]; [@bib55]; [@bib15]), and found that genes that overlapped with only the RGC axon translatome were twice as likely to be downregulated as upregulated; in contrast, the converse was true of genes in the cultured axon transcriptomes ([Figure 4f](#fig4){ref-type="fig"}). Regulated genes generally had more overlap with datasets from less mature axons, suggesting similar regulation of axonal translation during learning and development ([Figure 4---figure supplement 2b](#fig4s2){ref-type="fig"}). Upregulated genes were much more likely to overlap with genes downregulated rather than upregulated in response to injury ([@bib55]), consistent with similar translation patterns leading to depletion from the transcriptome.

Transcript-level correspondence of axonal and cortical mRNA {#s1-6}
-----------------------------------------------------------

Because alternative splicing could differ between the axons and cortex, we used Cufflinks software to compare expression at the transcript level. This analysis identified three genes that were not regulated at the gene level, but had one transcript upregulated (*Gng2*) or downregulated (*Snx27, Speg*) in axons while a second transcript was not ([Figure 4---figure supplement 3a](#fig4s3){ref-type="fig"}). Although multiple transcripts were identified for 133 (6%) of the 2185 differentially expressed genes, only one, *Gria2*, had one transcript significantly enriched in axons and another in cortex. Of the 656 genes that were associated with learning in both the axons and cortex, 54 had more than one transcript, and in 9nine cases, the same transcript was regulated in both ([Figure 4---figure supplement 3b--c](#fig4s3){ref-type="fig"}). To assess how learning-associated effects were distributed among transcripts in the two areas, we calculated a 'contribution score' for each transcript, indicating the fraction of the effect on its parent gene it represents. These scores were correlated between the axons and cortex ([Figure 4g](#fig4){ref-type="fig"}), indicating a high degree of coordinated regulation transcript level, similar to that seen at the gene level. Nevertheless, nine genes had transcripts whose axonal and cortical scores differed by \>0.3, meaning that more than 30% of the learning effect was on different transcripts ([Figure 4---figure supplement 3b--c](#fig4s3){ref-type="fig"}).

Imaging axonal mRNA {#s1-7}
-------------------

To verify axonal localization of mRNA in the amygdala in vivo, we used fluorescence in situ hybridization (FISH) combined with immunolabeling for axonal neurofilaments. We chose four transcripts that were abundant in control axons and significantly downregulated after learning: the Ras-related protein *Rab3a*, which regulates synaptic vesicle fusion, the N-myc downstream regulated gene *Ndrg4*, the Rab GDP dissociation inhibitor *Gdi1*, and *Ap2m1*, a subunit of the adaptor protein complex two which mediates synaptic vesicle endocytosis. We chose downregulated transcripts on the theory that these may represent constitutively translated genes in the control condition and would thus be less susceptible to varying translation levels over the course of consolidation. Successful FISH labeling required target retrieval treatments, including protease digestion, which proved incompatible with immunolabeling of cytoplasmic GFP in TE3 axons. The monoclonal antibody cocktail SMI312, which recognizes heavily phosphorylated axonal neurofilaments, was used to identify axons. Rats were given control training and brains were collected at the same time point as in the TRAP experiments. All four mRNA probes, but not the negative control probe, showed punctate labeling in the LA neuropil, with some puncta colocalized with axonal neurofilaments ([Figure 5](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Because the z-resolution of confocal microscopy may not be sufficient to unambiguously confirm colocalization, we repeated the labeling on 100 nm resin-embedded sections. The commercial FISH system we initially used did not work on these sections, so we used a traditional FISH protocol with an oligo(dT) probe. This probe revealed the expected pattern of poly-A RNA concentrated in cell bodies as well as both diffuse and punctate labeling throughout the neuropil, some of which colocalized with SMI312 ([Figure 6a](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Comparison of co-localization of the two labels revealed that a substantial amount of SMI312 label in the neuropil colocalized with oligo(dT) label ([Figure 6b](#fig6){ref-type="fig"}), while much less oligo(dT) was colocalized with SMI312. These observations further confirm the presence of mRNA in axons, and are consistent with the expectation that much of the oligo(dT) in the neuropil is in dendrites and glial processes.

![Axonal localization of mRNAs in vivo.\
First row: FISH showing localization of four mRNAs, but not a control probe, in amygdala neuropil. Second and third rows: Immunolabeling with the pan-axonal neurofilament antibody SMI312 shows overlap with mRNA probes. Bottom row: XZ orthogonal view of merged images. Scale = 5 µm.](elife-51607-fig5){#fig5}

![Colocalization of poly-A RNA with axonal neurofilaments in 100 nm resin-embedded amygdala sections.\
(**a**) Widefield images show overlap between and oligo(dT) probe and the pan-axonal neurofilament antibody SMI312 in the neuropil. Scale = 5 µm. (**b--c**) Mander's colocalization coefficients show a greater fraction of SMI312 signal colocalized with oligo(dT) in the neuropil versus the soma (**b**), but no difference oligo(dT) colocalized with SMI312 (**c**). \* F~(1,32)~ = 24.34, p=0.00002, η^2^ = 0.43.](elife-51607-fig6){#fig6}

Results and discussion {#s2}
======================

Our results demonstrate that local translation occurs in axons of the adult forebrain in vivo, and that regulation of the axonal translatome within a memory circuit is associated with learning. This supports a growing body of evidence that mature axons are capable of local translation, contrary to traditional assumptions, and suggests that gene expression is more extensively decentralized than previously thought. A striking and unexpected feature of our data was the extent of opposing changes in the cortex and axons, suggesting highly coordinated regulation between the two compartments. In dendrites, mRNA transport is activity-regulated, with different trafficking mechanisms exist for different mRNAs ([@bib54]; [@bib10]; [@bib5]), and the axonal transcriptome could be similarly regulated. Neurotrophic factors have been shown to induce transport of existing mRNAs from the soma into the axons of cultured DRG neurons, and this is selective for transcripts encoding cytoskeletal proteins ([@bib63]). The redistribution of transcripts from the soma to the axons could likewise be due to transport associated with learning. A large range of velocities has been reported for mRNA transport in neural processes ([@bib5]), and it is unknown whether mRNA travels from cortical cells to their distal projection fields in vivo in the timeframe of our experiment.

Because we analyzed ribosome-bound mRNAs, not the total mRNA in cortical cells, our data reflect not only mRNA localization but translation regulation as well. Downregulated transcripts may reflect termination and subsequent degradation, whereas upregulated transcripts presumably represent new initiation, with or without new transcription. After initiation, ribosomes can be stalled on mRNAs, which are subject to regulated transport and reactivation ([@bib41]). The TRAP method captures all ribosome-bound mRNA and cannot differentiate stalled ribosomes from those in an active elongation process at the moment of tissue harvest. Some of the mRNAs in our dataset are likely bound to stalled ribosomes, either because the transcripts are undergoing transport or are anchored in a dormant state awaiting reactivation. In addition, mRNAs can be transported and stored in a dormant state prior to initiation ([@bib5]). Rather than being newly trafficked from the soma, transcripts upregulated in the axons could result from unmasking of preexisting axonal mRNAs, and concomitant depletion from the cortex does not preclude upregulation of new, masked transcripts. Transcripts downregulated in the axons could reflect accelerated elongation in response to learning, or activation of stalled ribosomes, potentially with initiation and subsequent stalling of transcripts in the cortex to replenish the axonal supply. Finally, it should be noted that with the TRAP method, it is possible that the mRNAs that are isolated could be extraribosomal. Thus, additional work with multiple approaches will be required to elucidate the full extent of the axonal transcriptome and the dynamics of its translation.

Our cortical samples contained intrinsic and corticocortical axons, and it is therefore possible that some of our data derive from asynchronous changes in proximal versus distal axons, potentially due to more rapid trafficking of mRNA from the soma or differential regulation in the proximal axons. We found an assortment of translation initiation factors and genes coding for them, along with spliceosome components, in axons, making it likely that at least some axonal translation is locally initiated. The presence of genes associated with structures surrounding axons, such as myelin basic protein (*Mbp*), spinophilin (*Ppp1r9b*), dendrin (*Ddn*), and the shank proteins (*Shank1, 2, and 3*), could reflect previously unknown axonal functions of these proteins, as perhaps evidenced by the presence of *Mbp* mRNA in unmyelinated cultured axons ([@bib15]). Alternatively, this could result either from trans-endocytosis between dendritic spines and axonal boutons ([@bib53]) or exosomal transfer between myelin and the axon shaft ([@bib12]; [@bib59]). Translation regulation in axons is likely to be extensively regulated through multiple mechanisms, the details of which are yet to be fully discovered.

A potential source of bias in our data is the use of RPL10a to capture ribosome-bound mRNA. There is emerging evidence that some ribosomal proteins preferentially translate particular subsets of mRNAs ([@bib65]), including RPL10a, which has been found to have a bias for genes associated with the extracellular matrix and development in mouse embryonic stem cells ([@bib49]). If similar ribosome selectivity occurs in the adult brain, our dataset may not reflect the full diversity of the axonal translatome. Our viral TRAP approach relies on overexpression of the modified RPL10a protein, so it is possible that the complement of ribosomal proteins is altered with more RPL10a in axons than normal. Translation is subject to a very high degree of regulation, most of which occurs at the initiation step, and the rate-limiting factor is eIF4E, which recruits ribosomes to mRNA ([@bib14]; [@bib52]). Therefore, excess ribosomal proteins would not be expected to alter translation dynamics. Consistent with this prediction, the original report of the TRAP technique found no functional differences between overexpressed RPL10a-eYFP and endogenous RPL10a ([@bib17]).

The differences we observed between our trained and control groups can be attributed generally to learning, but our data do not address the potentially different effects of various forms of experience-dependent plasticity on the axonal translatome. The Pavlovian conditioning protocol that we used produces a specific type of associative learning, in which an excitatory relationship between the tone and the shock is established. A commonly used control for this procedure is unpaired training, which explicitly separates the tones and shocks so that the tones never predict the shocks. Unpaired training is itself an associative learning paradigm, however: it produces both an excitatory association between the training context and the shock and an inhibitory association between the tone and shock, with corresponding changes in LA synapses ([@bib42]; [@bib37]). Because there were no reference datasets to serve as benchmarks for an axonal translatome of an adult animal under quiescent conditions, we chose not to compare associative learning paradigms, but instead to use a control group that did not undergo learning. There is no way to entirely avoid learning when novel stimuli are presented; in the absence of shocks, exposure to tones induces remapping of the receptive fields of auditory cortical neurons that reduces responses to the habituated tone ([@bib7]), and also produces latent inhibition, a form of learning that produces a null association to the stimulus and impairs subsequent associations ([@bib62]). Thus, exposing the control group to tones on the training day, even without shocks, would have resulted in learning. Although habituation to the tone ahead of time would mitigate this, it would result in altered auditory circuits and require equal habituation of the trained group, which would interfere with learning. Our data therefore do not solely represent effects specific to the excitatory association, but likely include effects that are broadly induced by different forms of learning. More targeted experiments will be needed in the future to isolate and compare changes in the axonal translatome that are specific to excitatory versus inhibitory associations, and non-associative learning.

The spatiotemporal uncoupling of translation from transcription has unique implications in the brain, which is itself functionally compartmentalized. The increasing use of gene expression to catalog cells and brain areas, along with genetic targeting of brain circuits, will need to be reexamined if axonal translation is widespread in the adult brain. The idea that translation can be spatially regulated has gradually gained acceptance in a number of contexts, but these continue to be considered exceptional circumstances. Our results counter the longstanding assumption that axonal translation does not occur in the adult brain, and the number and variety of transcripts we identified suggests that spatial regulation could be a fundamental component of translation.

Materials and methods {#s3}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type              Designation                                    Source                                                           Identifiers                                                    Additional\
                                                                                                                                                                                                           information
  ------------------------- ---------------------------------------------- ---------------------------------------------------------------- -------------------------------------------------------------- ---------------------------------------------------
  Antibody                  Rabbit polyclonal anti-eIF4E                   Bethyl Labs                                                      Cat\# A301-154A                                                1:500 (EM-IHC)

  Antibody                  Mouse polyclonal anti-eIF4G1                   Abnova                                                           H00001981-A01                                                  1:500 (EM-IHC)

  Antibody                  Mouse monoclonal anti-eIF2α                    Cell Signaling                                                   L57A5                                                          1:500 (EM-IHC)

  Antibody                  mouse monoclonal anti-GFP                      Invitrogen                                                       A11120                                                         1:1000 (EM-IHC)

  Antibody                  mouse monoclonal anti-neurofilament cocktail   BioLegend                                                        SMI312                                                         1:500 (IHC); 1:250 (IHC)

  Antibody                  mouse monoclonal anti-GFP                      PMID: [24810037](https://www.ncbi.nlm.nih.gov/pubmed/24810037)   RRID:[AB_2716736](https://scicrunch.org/resolver/AB_2716736)   .29μg/μl

  Antibody                  mouse monoclonal anti-GFP                      PMID: [24810037](https://www.ncbi.nlm.nih.gov/pubmed/24810037)   RRID:[AB_2716737](https://scicrunch.org/resolver/AB_2716737)   .29μg/μl

  Recombinant DNA reagent   pAAV-CMV-eYFP-L10a                             PMID: [24904046](https://www.ncbi.nlm.nih.gov/pubmed/24904046)                                                                  Dr. Thomas Launey (RIKEN Brain Science Institute)

  Recombinant DNA reagent   VSVG.HIV.SIN.cPPT.CMV.eYFP-L10a                this paper (Materials and methods)                                                                                              

  Software, algorithm       Fiji                                           PMID: [22743772](https://www.ncbi.nlm.nih.gov/pubmed/22743772)   RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Subjects, surgery, and behavior {#s3-1}
-------------------------------

All animal procedures were approved by the Animal Care and Use Committees of New York University and the University of Connecticut. Subjects were adult male Sprague-Dawley rats weighing \~300 g, housed singly on a 12 hr light/dark cycle with ad libitum food and water. All procedures were performed during the rats' light cycle. For virus injections, rats were anesthetized with ketamine/xylazine and given bilateral stereotaxic injections of either 0.2 μl AAV-CMV.eYFP-L10a or 1 μl lenti-CMV.eYFP-L10a or lenti-CMV.eYFP (Emory Neuroscience Viral Vector Core) into TE3 (AP 3.8, ML 6.8, DV 3.7 mm from interaural center) using a Hamilton syringe. Animals were given at least two weeks to recover from surgery before experiments began.

Behavioral training took place in a soundproof, lit 28.5 × 26×28.5 cm chamber (Coulbourn Instruments). Auditory tones (30 s, 5 kHz, 80 dB) were delivered through a speaker inside the chamber, and footshocks (0.7mA, 1 s) were delivered through a grid floor. Rats were habituated to the conditioning chamber for 30 min for 2 days prior to training. The training protocol consisted of five tones co-terminating with foot shocks delivered over 32.5 min with a variable interval between tone-shock pairings.

Immunolabeling and electron microscopy {#s3-2}
--------------------------------------

Rats were deeply anesthetized with chloral hydrate (1.5 mg/kg) and perfused transcardially with 500 ml of mixed aldehydes at pH 7.4 at a rate of 75 ml/min with a peristaltic pump. For eYFP immunolabeling, two lentivirus-injected and two uninjected rats were perfused with 0.25% glutaraldehyde/4% paraformaldehyde/4 mM MgCl~2~/2 mM CaCl~2~ in 0.1M PIPES buffer. For eIF4E and eIF4G labeling six rats were perfused with 0.5% glutaraldehyde/4% paraformaldehyde/4 mM MgCl~2~/2 mM CaCl~2~ in 0.1M PIPES buffer and alternate sections were used for each antibody. For eIF2α six rats were perfused with 0.25% glutaraldehyde/4% paraformaldehyde in 0.1M phosphate buffer. For ribosomal protein S6 labeling, three rats were perfused with 0.1% glutaraldehyde/4% paraformaldehyde in 0.1M phosphate buffer. Aldehydes and PIPES buffer were obtained from Electron Microscopy Sciences, phosphate buffer and salts were from Sigma-Aldrich. Brains were removed and immersed in the perfusion fixative for one hour before rinsing in buffered saline (0.01M fixation buffer with 154 mM NaCl) and sectioning at 40 μm on a vibrating slicer. Sections were blocked for 15 min in 0.1% sodium borohydride, rinsed in buffer, and blocked in 1% bovine serum albumin (BSA; Jackson Labs) before overnight incubation in primary antibody in 1% BSA at room temperature. Sections were rinsed, incubated in 1:200 biotinylated goat anti-rabbit or goat anti-mouse (Vector Labs) in 1% BSA for 30 min, rinsed, incubated in avidin/biotin complex peroxidase reagent (Vector Labs Vectastain Elite ABC PK-6100) for 30 min, then reacted 5 min with 1 mM 3,3 diaminobenzidine in 0.0015% H~2~O~2~.

All sections from the brains injected with LV-CMV-eYFP-L10a were examined to confirm that there were no infected cell bodies outside of the TE3 injection site. The area around the LA was dissected out of the immunolabeled sections for electron microscopy. Tissue was processed for electron microscopy as previously described ([@bib37]). Briefly, tissue was postfixed in reduced osmium (1% osmium tetroxide/1.5% potassium ferrocyanide) followed by 1% osmium tetroxide, dehydrated in a graded series of ethanol with 1.5% uranyl acetate, infiltrated with LX-112 resin in acetone, embedded in resin, and cured at 60° for 48 hr. 45 nm sections were cut on an ultramicrotome (Leica) and imaged on a JEOL 1200EX-II electron microscope at 25,000X on an AMT digital camera. Images were cropped and contrast adjusted using Photoshop (Adobe).

For quantification of eIF4E immunolabel, serial 45 nm sections (average 97+ /- 5) were imaged from each of the six samples. A 4 × 4 µm square was defined in the middle of the central section of each series, and every profile within the square was followed through serial sections to determine its identity and whether it contained label within the series. If a profile could not be definitively identified as an axon, dendrite, spine, or glial process within the series, it was classified as unidentified.

Antibodies {#s3-3}
----------

Antibody sources and dilutions for immunohistochemistry were as follows: anti-eIF4E rabbit polyclonal (Bethyl Labs A301-154A, lot\# A301-154A-1) 1:500, anti-eIF4G1 mouse polyclonal (Abnova H00001981-A01, lot\# 08213-2A9) 1:500, anti-eIF2α mouse monoclonal (Cell Signaling L57A5, lot\# 3) 1:500, anti-GFP mouse monoclonal (Invitrogen A11120, clone\# 3E6) 1:1000, and anti-neurofilament (highly phosphorylated medium and heavy) mouse monoclonal cocktail (BioLegend SMI312 Lot\# B263754) 1:1000 for RNAscope experiments and 1:250 for labeling 100 nm resin sections. To confirm antigen recognition by the polyclonals to eIF4E and eIF4G, the primary antibodies were preadsorbed before use with a 10-fold excess of the immunizing peptide obtained from the antibody supplier, which reduced the density of labeled structures by 97--98%. To control for specificity of the GFP antibodies, tissue from animals without viral injections was run in parallel and did not result in labeled structures. For immunoprecipitation of eYFP-L10a, two mouse monoclonal anti-GFP antibodies (HtzGFP-19F7 lot\# 1/BXC_4789/0513 and HtzGFP-19C8 lot\# 1/BXC_4788/0513; available from the Memorial Sloan-Kettering Cancer Center Monoclonal Antibody Core Facility, New York, NY) were used as described below. SMI312 is a cocktail of affinity-purified mouse monoclonal antibodies that recognize highly phosphorylated medium and heavy neurofilament polypeptides.

Cloning and virus packaging {#s3-4}
---------------------------

pAAV-CMV-eYFP-L10a was a generous gift from Dr. Thomas Launey (RIKEN [@bib30]). YFP-L10a was excised from pAAV-CMV-eYFP-L10a using Nhe I and Xho I. The \~1.4 kb band was gel purified (QiaQuick Gel Extraction Kit, Qiagen, Hilden, Germany). pLV-eGFP (purchased from Adgene) was digested with Xba I and Sal I, and the \~6.7 kb band was gel purified. The eYFP-L10a and pLV backbone were then ligated according to the manufacturer\'s protocol (T4 DNA ligase, ThermoFisher Scientific, Springfield Township, NJ). Virus (VSVG.HIV.SIN.cPPT.CMV.eYFP-L10a) was packaged by The University of Pennsylvania Vector Core. Viral titer was 2.29e09 GC (genome copies)/mL.

Immunoprecipitation and RNA isolation {#s3-5}
-------------------------------------

Exactly 90 min after the completion of behavioral training, rats (n = 10 per group) were deeply anesthetized with chloral hydrate (1.5 mg/kg) and perfused transcardially with 20 ml ice cold oxygenated artificial cerebrospinal fluid (ACSF) consisting of 125 mM NaCl, 3.3 mM KCl, 1.2 mM NaH~2~PO~4~, 25 mM NaHCO~3~, 0.5 mM CaCl~2~, 7 mM MgSO~4~, and 15 mM glucose with 50 µM cycloheximide. Brains were quickly removed, blocked coronally around the amygdala and auditory cortex, and the two hemispheres separated and incubated in the perfusion solution for 4--5 min. Each hemisphere was then bisected along the rhinal fissure. The cortex of the dorsal half was peeled away from the underlying hippocampus and the area containing TE3 was dissected out. A smaller block containing the amygdala was dissected from the ventral half by peeling away the ventral hippocampus, trimming off the cortex lateral to the external capsule and trimming away the hypothalamus and medial portion of the striatum. The TE3 and amygdala blocks were quickly frozen in liquid nitrogen and stored at −80°C. Control and trained animals were run in parallel and tissue was collected in the middle of the animals' light cycle.

The polysome purification and RNA extraction were performed according to published protocols ([@bib17]; [@bib30]). TE3 or amygdala tissues from five animals were pooled (resulting in two biological replicates per group for sequencing), as pilot experiments found that this yielded sufficient mRNA. Samples were homogenized in 2 ml of ice-cold polysome extraction buffer \[10 mM HEPES, 150 mM KCl, 5mMMgCl2, 0.5 mM DTT, one minitablet Complete-EDTA free Protease Inhibitor Cocktail (Roche), 100 µl RNasin Ribonuclease Inhibitor (Promega) and 100 µl SUPERase In RNase inhibitor (Ambion), 100 µg/ml cycloheximide\] in douncer homogenizer. Homogenates were centrifuged for 10 min at 2000 x g at 4°C. The supernatants were clarified by adding 1% IGEPAL CA-630 (SigmaAldrich) and 30 mM DHPC (Avanti Polar Lipids) and incubated for 5 min on ice. The clarified lysates were centrifuged for 15 min at 20,000 x g at 4°C to pellet unsolubilized material, and 100 µl of the supernatant fluid was collected for isolation of the tissue transcriptome. The remainder was added to the conjugated beads/antibodies (200 µl) and incubated at 4C overnight with gentle agitation. The following day, the beads were collected with magnets for 1 min on ice, then washed in 1 mL 0,35M KCl washing buffer (20 mM HEPES, 350 mM KCl, 5mMMgCl~2~, 0.5 mM DTT, 1% IGEPAL CA-630, 100 µl RNasin Ribonuclease Inhibitor and 100 µl SUPERase In RNase inhibitor, 100 µg/ml cycloheximide) and collected with magnets.

The conjugated beads/antibodies were freshly prepared before the homogenization on the day of the experiment by incubating 300 µl of Dynabeads MyOne Streptavidin T1 (ThermoFisher Scientific) with 120 µl of 1 µg/µl Biotinylated Protein L (ThermoFisher Scientific) for 35 min at room temperature with gentle rotation. Then, the conjugated protein L-beads were washed with 1XPBS and collected with magnets for three times. The conjugated protein L-beads were resuspended in 175 µl of 0.15M KCl IP wash buffer (20 mM HEPES, 150 mM KCl, 5mMMgCl~2~, 0.5 mM DTT, 1% IGEPAL CA-630, 100 µl RNasin Ribonuclease Inhibitor and 100 µl SUPERase In RNase inhibitor, 100 µg/ml cycloheximide) and incubated for 1 hr at room temperature with 50 µg of each antibody. The beads were then washed 3 times with 0.15M KCl IP wash buffer and resuspended in the same buffer with 30 mM DHPC.

The RNA was extracted and purified with Stratagene Absolutely RNA Nanoprep Kit (Agilent Technologies, Santa Clara, CA) according to the manufacturer's instructions. All the buffers were provided with the kit except otherwise specified. Briefly, the beads were resuspended in Lysis Buffer with ß-mercaptoethanol, incubated for 10 min at room temperature. 80% Sulfolane (Sigma) was added to the samples and the samples were mixed for 5--10 s, then added to an RNA-binding nano-spin cup and washed with a Low Salt Washing Buffer by centrifuge for 1 min at 12,000 x g at room temperature. DNA was digested by mixing the DNase Digestion Buffer and the samples for 15 min at 37C. Then, the samples were washed with High-Salt Washing Buffer, Low-Salt Washing Buffer and centrifuged for 1 min at 12,000 x g. Finally, the samples were eluted with Elution Buffer and centrifuge for 5 min at 12,000 x g at room temperature. The isolated RNA was stored at −80°C.

Sequencing and differential gene expression (DGE) analysis {#s3-6}
----------------------------------------------------------

RNASeq libraries were made using the SMART-Seq v4 Ultra Low Input RNA Kit for Illumina Sequencing, with the Low Input Library Prep kit v2 (Clontech, Cat \# 634890 and 634899, respectively), using 50--200 pg of total RNA. 16 cycles of PCR were used for the cDNA amplification step, and 5 PCR cycles to amplify the library prep. Libraries were run on an Illumina HiSeq 2500 instrument, using a paired end 50 protocol; eight samples were pooled per lane of a high output paired end flow cell, using Illumina v4 chemistry.

Raw sequencing data were received in FASTQ format. Read mapping was performed using Tophat 2.0.9 against the rn6 rat reference genome. The resulting BAM alignment files were processed using the HTSeq 0.6.1 python framework and respective rn6 GTF gene annotation, obtained from the UCSC database. Subsequently the Bioconductor package DESeq2(3.2) was used to identify differentially expressed genes (DEG). This package provides statistics for determination of DEG using a model based on the negative binomial distribution. The resulting values were then adjusted using the Benjamini and Hochberg's method for controlling the false discovery rate (FDR). Genes with an adjusted p-value\<0.05 were determined to be differentially expressed. For transcript-level analysis, the Cufflinks suite (version 2.2.1) was used. ANOVAs and post hoc Bonferroni tests were run using the STATISTICA software package (StatSoft). Raw sequencing data and analysis are available in the NCBI Gene Expression Omnibus (accession \# GSE124592).

Filtering of DGE results {#s3-7}
------------------------

To isolate the axonal translatome with as few false positives as possible, we employed a stringent filtering strategy to our DGE data. Twelve comparisons were run between the eight samples: the TRAPed mRNAs from the axons and cortex were compared to each other separately in each of the training conditions, and the conditions were compared to each other separately in the two brain areas. The same analysis was performed on the tissue transcriptome samples, and each of the four TRAPed samples was compared directly to its corresponding transcriptome. To assemble a list of axonal mRNAs, we began with the comparisons between the TRAPed samples, since this should account for much of the IP background. Because of potential background noise and variability between the individual samples preparations, we excluded genes from each TRAP comparison if the same effect was observed in the corresponding transcriptome comparison. In addition, genes enriched in a given comparison between TRAP samples were excluded if they were not also enriched versus the transcriptome. Although both of these steps likely result in many false negatives, particularly among transcripts that are highly abundant or ubiquitous in the tissue, we felt that excluding potential false positives was crucial given the novelty of our dataset.

Gene ontology and ingenuity pathway analysis {#s3-8}
--------------------------------------------

Gene lists were submitted to the DAVID ([@bib21]) Functional Annotation Chart tool and enrichment data from the GOTERM_BP_DIRECT (biological process), GOTERM_CC_DIRECT (cellular component), and GOTERM_MF_DIRECT (molecular function) gene ontology categories and KEGG_PATHWAY (Kyoto Encyclopedia of Genes and Genomes) category were examined, using a Benjamini-Hochberg adjusted p-value cutoff of \<0.05. For comparison of learning effects, all regulated genes in each area were submitted, regardless of any effect or enrichment in the other area.

For Ingenuity Pathway Analysis (Qiagen Bioinformatics), we submitted all genes differentially expressed (adjusted p-value\<0.05) between the training groups in the axons and cortex, along with the corrected log~2~(fold change) calculated by DESeq2. We performed a Core Analysis with the reference data restricted to human, mouse and rat genes and nervous system tissue; otherwise the program's default settings were used.

Fluorescence in situ hybridization on fixed sections {#s3-9}
----------------------------------------------------

Adult male rats (n = 4) were given control training and perfused 90 min later with 4% paraformaldehyde in 0.1M phosphate buffer, pH 7.4. Brains were sectioned at 40 µm on a vibrating tissue slicer (Leica) and mounted on glass slides. RNA was detected using the RNAscope 2.5 HD RED kit (Advanced Cell Diagnostics, Inc) according to the manufacturer's instructions, with the exception that the incubation time for the fifth amplification step was doubled to increase the diameter of the puncta. Each section was labeled with one of five probes: *Rab3a*, *Ndrg4*, *Ap2m1*, *Gdi1*, or *DapB* (negative control). Sections were blocked overnight in 1% bovine serum albumin with 0.1% Triton-X in phosphate buffered saline, then incubated with primary antibody for 48 hr at 4° followed by 1:200 Alexa-488 goat anti-mouse for 1 hr at room temperature. Slides were stained with DAPI, mounted in Prolong Gold (Invitrogen), and imaged on a Leica TCS SP8 confocal microscope (Leica Microsystems). Z stacks were collected using a 63 × 1.40 HC PL APO oil immersion lens and z step size of 0.3 microns. All sections were stained in parallel with the same batches of probes and antibody. Laser intensity and gain were constant for all images and brightness and contrast were not adjusted. Maximum intensity projections were created in ImageJ.

Fluorescence in situ hybridization on resin-embedded sections {#s3-10}
-------------------------------------------------------------

Adult male rats (n = 3) were perfused transcardially with 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1M phosphate buffer, pH 7.4. Brains were sectioned at 100 µm on a vibrating slicer and sections containing the amygdala were dissected. Sections were dehydrated through ascending ethanol dilutions, infiltrated with LR White resin (Electron Microscopy Sciences), and cured at 60° for 48 hr. 100 nm sections were cut on an ultramicrotome (Leica) and mounted on gelatin-coated glass slides for labeling. Sections were hydrated in PBT (PBS-pH7.4 + 0.1% Tween20) at room temperature for 5 min (3X) followed by incubation with oligo(dT)-ATTO633 probe (Integrated DNA Technologies) in hybridization buffer (5X SSC + 1X-Denhardt's buffer (Sigma -- D2532) + 5% Dextran Sulfate + 0.05M Phosphate buffere pH6.7 + 0.1% SDS) at 60C in a hydrated chamber. Post hybridization washes were done at 60C in 1X SSC + 50% deionized formamide/10 min; 2X SSC/5 min; 0.2X SSC/2 min. Sections were then washed in PBT for 5 min at room temperature followed by fixation in 4% paraformaldehyde for 10 min at room temperature. After washing the sections twice in PBT for 5 min at room temperature, they were blocked in PBT + 0.5% bovine serum for 5 min at room temperature. Sections were incubated in primary antibody followed by 1:200 Alexa-488 donkey anti-mouse, both for 30 min in the blocking solution. After blocking in 0.5% bovine serum albumin in phosphate buffered saline containing 0.1% Tween-20, sections were incubated in primary antibody followed by 1:200 Alexa-488 donkey anti-mouse, both for 30 min in the blocking solution. Slides were mounted in Prolong Gold and imaged on a Nikon Eclipse TiE microscope (Nikon Instruments) with a Photometrics Prime 95B CMOS camera (Teledyne Photometrics) using a 100 × 1.49 PL APO oil immersion lens. Colocalization was quantified using the Coloc2 plugin in Fiji. ([@bib46]) Background was removed from the images by subtracting the mean intensity of the no-primary antibody control images from the SMI312 channel, and subtracting the mean intensity of images of the resin surrounding the tissue from the oligo(dT)-ATTO633 channel. ROIs were drawn to segment the neuropil and somata (n = 17 per region) and thresholded using the Costes method. ([@bib8]) One-way ANOVAs were used to compare Manders colocalization coefficients ([@bib31]) for each channel between the soma and neuropil.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Local translation is important for memory consolidation by supplying new proteins to new synaptic connections to stabilize them. This work demonstrates that translation in adult forebrain dendrites is regulated by learning. Axons in the adult rat amygdala contain translation machinery, and the authors used translating ribosome affinity purification (TRAP) with RNASeq to identify mRNAs in cortical axons regulated during associative memory. Mitochondrial and translation-related genes were upregulated, whereas synaptic, cytoskeletal, and myelin-related genes were downregulated. Their results demonstrate that learning-regulated axonal translation occurs in the adult forebrain.

These are important observations for the neuroscience field, especially for neuronal-oriented cell biologists in the areas of learning and memory. It will also be of interest for RNA biologists interested in translational regulation because it opens the pathway to investigating the mechanisms by which translation is regulated in complex cells such as neurons.

**Decision letter after peer review:**

Thank you for submitting your article \"The translatome of adult cortical axons is regulated by learning in vivo\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Eve Marder as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Pablo E Castillo (Reviewer \#2); Christine E Holt (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary (from reviewer 3):

This manuscript investigates the question of whether translation in the presynaptic compartment in the mammalian cortex is altered by learning. The authors provide immuno EM evidence that axons in the rat amygdala contain translation-associated machinery and use TRAP and RNASeq to characterise the ribosome-bound mRNAs in cortical axons projecting to the amygdala under different learning paradigms. They report that over 1200 mRNAs are regulated during the consolidation of associative memory. Mitochondrial and translation related genes, particularly, were upregulated whereas other genes such as synaptic, cytoskeletal and myelin-related, were downregulated. Also, of interest, opposite up/down gene regulation occurred in the cortex. The authors conclude that learning-regulated translation changes occur in axons of the forebrain and suggest that they may be widespread and important for learning.

Essential revisions:

While the reviewers find the work interesting and important, they feel that there should be more evidence that learning leads to local translation and subsequent presynaptic plasticity: that localization of mRNAs and their translation in axons can be related to memory consolidation. They suggest higher resolution imaging and use of more specific antibodies as possible approaches. In particular, reviewer 2 suggests an additional control and would like higher resolution evidence that the mRNAs are actually in axons. Additional suggestions include using translation indicators (e.g. antibodies for phosphorylated initiation factors). Reviewer 3 has suggestions concerning how the data was analyzed.

*Reviewer \#1:*

In the manuscript submitted by Ostroff et al., the authors describe the identity of axonal translatome within the lateral amygdala following auditory fear condition. Intriguingly, the results show an increase in the synthesis of mitochondrial and translation machinery-related proteins after learning. Moreover, the selective translation of such genes was most similar to the translatome of immature/growing/axotomized axons or axonal translatome of juvenile mice. These findings are quite unexpected and provide strong evidence that axons are capable of altering their translatome after fear conditioning. Lastly, these and recent findings by others are challenging the notion that adult axons are not capable of producing proteins locally.

On the technical side, it can be argued that TRAP-RNAseq and EM have been demonstrated in numerous publications and lacks novelty. However, as sequencing technologies and gene ontology algorithms are improving, it is necessary to i) compare and validate earlier works and to ii) establish and annotate transcriptomes/translatomes from different regions of the brain. Such works are important in establishing a methodology to study transcriptome-wide local gene expression in the context of behavioral paradigms-providing a physiological link to axonal translation.

The writing is unclear and needs to be stronger:

-- While it is understandable that figures from transcriptome-wide studies are information-rich and overwhelming in the amount of data, it does not mean that the results should be annotated sloppily, left unclear or unexplained.

• Subsection "Isolation of the adult axonal translatome", third paragraph: when explaining differential gene expression (DGE) analyses, the paragraph seems deliberately confusing by comparing two groups (translatome vs transcriptome) of two (axons vs cortex) by another set of two (experimental vs control) which all becomes undecipherable in Supplementary file 2. Should there be 16 sets of results?

• Subsection "Isolation of the adult axonal translatome", fourth paragraph: it would be more intuitive if the selection process as noted in Figure 3---figure supplement 2A would go from a large population to small (transcriptome\>\>TRAP), even if the experimental work flow does not mirror that.

• If showing a number or a fraction of a population of genes, include (%) or vice versa as it is not clear which figures the numbers or percentages were taken from (subsections: "Isolation of the adult axonal translatome", last paragraph; "Opposite learning effects in axons and cortex", first paragraph; "Transcript-level correspondence of axonal and cortical mRNA".

-- The organizational structure of the manuscript should be changed:

• The EM data/Figures 1,2 should go after the TRAP results as supporting the TRAP outcome rather than before. The EM polysome data segues nicely from the TRAP data as there was very little explanation on why axons exhibited increased translational machinery-related mRNAs.

*Reviewer \#2:*

In this provocative study, Ostroff et al. report that cortical axons projecting to the lateral amygdala in the adult rat brain contain translation machinery and mRNA translation seems to be regulated after a manipulation expected to induce associative memory in rats. Intriguingly, using TRAP with RNAseq they identified a number of mRNA transcripts that were upregulated and downregulated in axons, whereas the opposite effect was observed in cortex, suggesting a coordinated regulation between these two compartments. If true, this study represents the first demonstration for learning-regulated axonal translation in the adult mammalian brain. The relevance of this local translation to learning is assumed but never tested. What proteins are synthesized and degraded remain unknown. There is growing evidence for presynaptic protein synthesis in the adult mammalian brain and the authors seem to suggest that axonal mRNA translation could be linked to presynaptic plasticity but they do not directly address this point (not even in Discussion). While the findings are potentially significant, there are a number of claims that are not fully supported by the results.

1\) The authors claim axonal protein translation occurs during memory consolidation. They also state that long-term memory formation requires de novo translation during a critical period of several hours after training and that they sacrificed animals during this time window. However, as indicated in Figure 3A measurements took place 90 min post training. Thus, the findings may not be related to memory consolidation but presynaptic protein synthesis that occurs before memory consolidation. Moreover, the authors claim axonal translation is triggered by associative learning in animals receiving paired CS+US compared to a naïve animal receiving no stimulation. To claim that associative learning induced axonal translation, control animals should receive unpaired CS+US.

2\) Could the authors demonstrate learning-induced translation by measuring phospho eIF4E or S6 kinase in axons? Also, what percentage of axonal ribosomes are actively translating?

3\) In Figure 5, the authors attempt to provide further evidence of mRNA localization in axons in vivo. While these data are important, the resolution that can be achieved with a laser scanning confocal microscope is only 120 nm in the xy plane, and considerably worse in the z-plane. At this distance, it is nearly impossible to argue that any FISH probes are actually contained within the axon and not in somas, dendrites, glia or anything else in the surrounding tissue. In order to convince the reader that these mRNAs are specific to axons, perhaps they could immunolabel for MAP2 and demonstrate that the target mRNAs are more often colocalized with SMI312 compared with dendritic MAP2. Alternatively, a cell-specific or higher resolution approach is needed. Lastly, the rationale for choosing mRNAs that are downregulated during learning is a bit unclear. Why not look at mRNAs upregulated under control conditions?

4\) How specific are eukaryotic initiation factor antibodies? To strengthen the authors\' claim for axonal translation machinery it is important to report the extent of labeling for another marker such as a ribosomal protein.

5\) There seems to be a disconnect between presynaptic LTP that is supposedly induced by training and the reduction of synaptic transcripts. How do the authors explain that synapses are strengthened while synaptic proteins (e.g. Rab3A, others) are downregulated?

*Reviewer \#3:*

This manuscript investigates the question of whether translation in the presynaptic compartment in the mammalian cortex is altered by learning. The authors provide immuno EM evidence that axons in the rat amygdala contain translation-associated machinery and use TRAP and RNASeq to characterise the ribosome-bound mRNAs in cortical axons projecting to the amygdala under different learning paradigms. They report that over 1200 mRNAs are regulated during the consolidation of associative memory. Mitochondrial and translation related genes, particularly, were upregulated whereas other genes such as synaptic, cytoskeletal and myelin-related, were downregulated. Also, of interest, opposite up/down gene regulation occurred in the cortex. The authors conclude that learning-regulated translation changes occur in axons of the forebrain and suggest that they may be widespread and important for learning.

This is an interesting study that reports novel findings. Previous work has taken a genome-wide approach to investigating the presynaptic translatome during learning but this has not been done for the presynaptic compartment. Indeed, axonal translation has historically been a controversial area and, although it is now broadly accepted, the important question of whether there are presynaptic changes in local translation associated with plasticity and learning in adult axons has not been investigated. The evidence presented in the manuscript is compelling and the data analysis is careful and thorough. The manuscript is written clearly and well and care is taken to give the background and rationale. Overall, this is an excellent study that adds strong in vivo evidence that local translation occurs in adult CNS axons and, further, suggests a potentially important functional role during learning. In addition, the RNASeq datasets will serve as an important resource for learning-regulated axonal translation. I have a few comments (see below) that may help improve the manuscript.

1\) An unexpected and interesting finding in this study is the opposite learning effects in the axonal translatome and the cortex translatome. Although the authors suggest the possibility that compartment-specific translation is coordinated within the cell, the interpretation of this finding is not straightforward because it is not clear what the cortex translatome represents. It would be useful to see an estimate from previous literature or from additional experiments (e.g. staining for markers) indicating which types of cells express the tagged ribosome in the cortex sample and whether the neurons projecting axons to the amygdala are predominant among them.

2\) In terms of the filtering method, it is confusing to use the words \"axonal translatome\" for the gene set that consists of two differently filtered groups: 1) the genes enriched in the axons versus the cortex and 2) those changed by the training. Their filtering excludes a lot of axonally translated genes whose translation levels are not changed by the training and not significantly higher than the translation in the cortex. Why don\'t the authors filter genes simply by TRAPed vs input (transcriptome) or by TRAPed vs YFP control in the basal (untrained) condition? In this context, the statement that \"The majority of genes in the translatome (75%) were regulated by learning\" is misleading as these regulated genes were enriched by the filtering.

\[Editors' note: this article was subsequently rejected after discussions between the reviewers, but the authors were invited to resubmit.\]

Thank you for submitting your work entitled \"The translatome of adult cortical axons is regulated by learning in vivo\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Pablo E Castillo (Reviewer \#2); Christine E Holt (Reviewer \#3).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered for publication in *eLife* in its current form. Both reviewers cite serious enough concerns to obviate publication that were not addressed in the revision. These concerns focus on the lack of proper controls and interpretation of the data. Their detailed responses are below.

The reviewers still feel the work has merit and if you feel that you can address the concerns with additional data, we will consider it as a new submission. However you may wish to transfer or submit to another journal. eLfe feels strongly that authors should not do extensive new work if they do not agree with the reviewers. So if you agree, we would be happy to see the manuscript back. If you disagree, we would strongly urge you to submit elsewhere.

Reviewer \#2:

The authors have addressed some of my concerns but important issues remain unresolved.

I still think that better control experiments are required in order to claim that learning regulates the axonal translatome. To my suggestion of testing unpaired CS+US, the authors responded this protocol triggers a different form of learning which is associated with mechanistically unknown forms of synaptic plasticity. Because changes in the translatome can occur by neuronal activity triggered by CS (or US), not necessarily learning, naïve animals are not a proper control. At present, the authors\' findings cannot distinguish between learning and neuronal activity induced by CS or US. Unless the authors use proper controls (e.g. CS or US, other protocol that include similar neuronal activity that paired CS+US) and unequivocally demonstrate that learning, but not neuronal activity alone, is sufficient to change the presynaptic translatome, they should remove learning as a trigger of the observed changes in the translatome. Learning-induced regulation of the translatome is presumably the most novel component of this study and therefore, much more convincing evidence is required.

The authors acknowledged that eIF antibodies may not be that specific. They explain that these essential factors cannot be genetically removed and therefore, the antibody specificity cannot be validated. This is precisely why I requested they should use a different antibody, e.g. against a ribosomal protein. The authors responded they immunolabled the ribosomal protein S6 and even observed axonal labelling with \"all these factors/proteins\". However, no immunoEM image labelling presynaptic/axonal rpS6 is provided.

To my request that Figure 2 should include widefield immunolabeling of YFP in lateral amygdala, the authors responded their \"entire stock of virus was used\" and that they \"are unable to generate a new batch of tissue for this purpose\". I am not persuaded by this response.

New results reported in Figure 6 are interesting but must include some quantification -e.g. extent of background labelling v. real signal. All the reader sees is some colocalization examples using poly-A RNA rather than individual mRNAs. The difference between the commercial FISH system and the \"traditional FISH protocol\" is not obvious and should be better clarified in the text. Lastly, the calibration bar in Figure 6 is wrong (5 μm but not 5 nm).

Reviewer \#3:

Although I still generally support the publication of this manuscript, I found the authors\' responses to my comments disappointing.

Their answer to point 1 is cursory and, except for adding a reference indicating that the lentivirus is selective for excitatory neurons, they do not attempt to clarify further what the cortex translatome represents.

To point 2, they do not appear to have tried to address the comment that their statement \"The majority of genes in the translatome (75%) were regulated by learning\" is misleading as these regulated genes were enriched by the filtering. The text remains basically the same (\"The majority of genes in the translatome (1647 of 2185 or 75%) were regulated by learning\" without a qualification or modification.

To the point about clarifying their use of the term the \'translatome\', the authors need to be more explicit about the fact that they are looking only at ribosome-bound mRNAs and acknowledge that they have not tested the true percentage of mRNAs being translated as they have not performed standard methods to look at this (ribosome foot-printing or ribosome run-off). This distinction is important in the field and should be included for accuracy. It is not sufficient to dismiss it by saying it is \'unwieldy\' to use a more accurate term. They simply need to accurately define their use of the term \'translatome\' here and acknowledge that they do not know what fraction of their ribosome-bound mRNAs are being translated, if any.

Related to this point is the troubling statement in the rebuttal that eYFP itself binds to mRNA to some extent. If this is the case then it seems all the more important to compare TRAP vs YFP. Since they are not using a knock-in RP model, it also raises the question of whether the exogenously expressed eYFP-Rpl10a actually incorporates into ribosomes in their system. It is possible that the mRNA changes they detect with YFP-pulldown reflect mRNAs binding to extraribosomal YFP-Rpl10a and do not, in fact, report translation. Some serious consideration of this point should be included.

I also do not understand their reasoning \"Because of the lack of consensus on what to expect in an axonal translatome and the longstanding dogma that it should not exist, we chose to focus on transcripts that we had the highest confidence were truly axonal.\" What factors determined their confidence?

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Axon TRAP reveals learning-induced alterations in cortical axonal mRNAs in the lateral amgydala\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Eve Marder as the Senior Editor, a Reviewing Editor, and two reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined by reviewer 2.

In short, the reviewer feels that the definition of learning needs to be clarified further in the text and some additional information provided.

Please incorporate some appropriate qualifications on the interpretations of the data into the text to address these concerns.

Reviewer \#1:

The authors have answered my recent comments in a satisfactory way. They should be commended on an excellent piece of work that will have a significant impact in the fields of learning and axonal translation.

Reviewer \#2:

The authors have addressed some of my concerns and the manuscript has improved, but key weaknesses remain. Although the word learning comes up 47 times in the text, the experimental evidence that learning -rather than neuronal activity- regulates the axonal translatome remains extremely weak. The authors point that \"one group of rats experienced some kind of learning\" is well-taken, however it does not justify the use of the phrases like \"learning-regulated\", which is found ubiquitously throughout the text. As I have mentioned before, the authors cannot distinguish between translatome changes that result from associative learning v. changes resulting from the foot shock or tone. Therefore, the most that they can reasonably claim is that in vivo neuronal activity (driven by specific learning paradigms) results in changes in the axonal translatome.

The fact that the authors do not observe eYFP labeling in the lateral amygdala is a bit concerning, presumably with confocal microscopy axons in the TE containing eYFP should be visible. That the authors do see eYFP labeling in axons with EM is encouraging, however it does not provide any index of the extent of the overexpression of RPL10a-eYFP construct. How much expression is needed to get sufficient mRNA? Is the amount of RPL10A-eYFP in axons consistent with the EM showing a few polyribosomes or does overexpression drive more RPL10A into the axons than is normal? Moreover, the authors do not report the amount of mRNA that was isolated, therefore it is hard to know whether the RNA isolated is of sufficient quality and quantity for subsequent RNAseq analysis.

10.7554/eLife.51607.sa2

Author response

> Essential revisions:
>
> While the reviewers find the work interesting and important, they feel that there should be more evidence that learning leads to local translation and subsequent presynaptic plasticity: that localization of mRNAs and their translation in axons can be related to memory consolidation. They suggest higher resolution imaging and use of more specific antibodies as possible approaches. In particular, reviewer 2 suggests an additional control and would like higher resolution evidence that the mRNAs are actually in axons. Additional suggestions include using translation indicators (e.g. antibodies for phosphorylated initiation factors). Reviewer 3 has suggestions concerning how the data was analyzed.
>
> Reviewer \#1:
>
> In the manuscript submitted by Ostroff et al., the authors describe the identity of axonal translatome within the lateral amygdala following auditory fear condition. Intriguingly, the results show an increase in the synthesis of mitochondrial and translation machinery-related proteins after learning. Moreover, the selective translation of such genes was most similar to the translatome of immature/growing/axotomized axons or axonal translatome of juvenile mice. These findings are quite unexpected and provide strong evidence that axons are capable of altering their translatome after fear conditioning. Lastly, these and recent findings by others are challenging the notion that adult axons are not capable of producing proteins locally.
>
> On the technical side, it can be argued that TRAP-RNAseq and EM have been demonstrated in numerous publications and lacks novelty. However, as sequencing technologies and gene ontology algorithms are improving, it is necessary to i) compare and validate earlier works and to ii) establish and annotate transcriptomes/translatomes from different regions of the brain. Such works are important in establishing a methodology to study transcriptome-wide local gene expression in the context of behavioral paradigms-providing a physiological link to axonal translation.
>
> The writing is unclear and needs to be stronger:
>
> -- While it is understandable that figures from transcriptome-wide studies are information-rich and overwhelming in the amount of data, it does not mean that the results should be annotated sloppily, left unclear or unexplained.
>
> • Subsection "Isolation of the adult axonal translatome", third paragraph: when explaining differential gene expression (DGE) analyses, the paragraph seems deliberately confusing by comparing two groups (translatome vs transcriptome) of two (axons vs cortex) by another set of two (experimental vs control) which all becomes undecipherable in Supplementary file 2. Should there be 16 sets of results?

There are a total of 12 sets of DGE results, but we did not intend for the text to be confusing. This has been rewritten for clarity.

> • Subsection "Isolation of the adult axonal translatome", fourth paragraph: it would be more intuitive if the selection process as noted in Figure 3---figure supplement 2A would go from a large population to small (transcriptome\>\>TRAP), even if the experimental work flow does not mirror that.

The steps shown were conducted after each DGE analysis, and we have clarified that in the legend. We have rearranged the flow chart as suggested, in order of the number of transcripts filtered out at each step

> • If showing a number or a fraction of a population of genes, include (%) or vice versa as it is not clear which figures the numbers or percentages were taken from (subsections: "Isolation of the adult axonal translatome", last paragraph; "Opposite learning effects in axons and cortex", first paragraph; "Transcript-level correspondence of axonal and cortical mRNA".

We have clarified these statements.

> -- The organizational structure of the manuscript should be changed:
>
> • The EM data/Figures 1, 2 should go after the TRAP results as supporting the TRAP outcome rather than before. The EM polysome data segues nicely from the TRAP data as there was very little explanation on why axons exhibited increased translational machinery-related mRNAs.

We certainly see the reviewer's point, although we respectfully disagree. In reality, the TRAP experiment was undertaken to confirm and explore our unexpected observations of polysomes and immunolabeling of translation machinery in axons by EM. The order of the manuscript does not necessarily need to reflect the initial logic of the project, of course, but here we feel that direct visualization of this elusive phenomenon sets the stage for deeper exploration in the form of sequencing data.

> Reviewer \#2:
>
> In this provocative study, Ostroff et al. report that cortical axons projecting to the lateral amygdala in the adult rat brain contain translation machinery and mRNA translation seems to be regulated after a manipulation expected to induce associative memory in rats. Intriguingly, using TRAP with RNAseq they identified a number of mRNA transcripts that were upregulated and downregulated in axons, whereas the opposite effect was observed in cortex, suggesting a coordinated regulation between these two compartments. If true, this study represents the first demonstration for learning-regulated axonal translation in the adult mammalian brain. The relevance of this local translation to learning is assumed but never tested. What proteins are synthesized and degraded remain unknown. There is growing evidence for presynaptic protein synthesis in the adult mammalian brain and the authors seem to suggest that axonal mRNA translation could be linked to presynaptic plasticity but they do not directly address this point (not even in Discussion). While the findings are potentially significant, there are a number of claims that are not fully supported by the results.

*1) The authors claim axonal protein translation occurs during memory consolidation. They also state that long-term memory formation requires* de novo *translation during a critical period of several hours after training and that they sacrificed animals during this time window. However, as indicated in Figure 3A measurements took place 90 min post training. Thus, the findings may not be related to memory consolidation but presynaptic protein synthesis that occurs before memory consolidation.*

The process of memory consolidation is generally characterized by successive waves of learning-induced gene expression cascades that begin within minutes and last for at least several hours. There is a substantial literature on translation of newly transcribed and pre-existing mRNAs over minutes to hours, and on transport of mRNA into dendrites over this period. In previous work, we observed increased polyribosomes in dendrites 30 minutes after learning. Distal axons are an order of magnitude farther from the soma than distal dendrites and reported rates of mRNA transport in neurons are highly variable. We chose a later time point, still well within the active consolidation phase, on the hypothesis that mRNAs may be trafficked from the soma and would need more time to travel to distal axons.

> Moreover, the authors claim axonal translation is triggered by associative learning in animals receiving paired CS+US compared to a naïve animal receiving no stimulation. To claim that associative learning induced axonal translation, control animals should receive unpaired CS+US.

We are indeed claiming that our trained group underwent associative learning and our control group did not, but we are not claiming that our observations are specific to the excitatory aversive association. Unpaired training produces conditioned inhibition, specifically safety learning in this case, a form of associative learning in which the CS acquires the ability to suppress fear and anxiety. We have found structural plasticity in the LA as a result of the unpaired protocol relative to the paired training and box control protocols presented here, and published several behavioral controls confirming conditioned inhibition (Ostroff et al., 2010). The unpaired protocol also results in reduced tone-evoked synaptic responses in the LA, opposite to the changes induced by paired training (Rogan et al., 1997 Nature; Rogan et al., 2005). The synaptic plasticity mechanisms of conditioned inhibition are unknown, so instead of comparing two related types of associative learning to each other, we chose to expose both groups to a familiar context and train only one.

> 2\) Could the authors demonstrate learning-induced translation by measuring phospho eIF4E or S6 kinase in axons? Also, what percentage of axonal ribosomes are actively translating?

This a great suggestion, but we have never succeeded in specifically immunolabeling phosphorylated proteins in fixed tissue, presumably due to continued activity of phosphatases during and after aldehyde fixation or to the lower number of epitopes specific to a phosphorylated state. We do not know of a straightforward method for assessing the temporal dynamics of active translation in this paradigm. The presence of initiation factors in axons suggests that translation may be initiated in at least some transcripts in the axons, as opposed to 100% of axonal ribosome-bound transcripts having undergone initiation in the soma. In addition, it is possible that transcripts TRAPed in the control axons, but not trained axons, were translated locally before being degraded. Experiments to directly assess in vivorates of translation of ribosome-bound transcripts would require extensive protocol development that is beyond the scope of this study.

*3) In Figure 5, the authors attempt to provide further evidence of mRNA localization in axons* in vivo*. While these data are important, the resolution that can be achieved with a laser scanning confocal microscope is only 120 nm in the xy plane, and considerably worse in the z-plane. At this distance, it is nearly impossible to argue that any FISH probes are actually contained within the axon and not in somas, dendrites, glia or anything else in the surrounding tissue. In order to convince the reader that these mRNAs are specific to axons, perhaps they could immunolabel for MAP2 and demonstrate that the target mRNAs are more often colocalized with SMI312 compared with dendritic MAP2. Alternatively, a cell-specific or higher resolution approach is needed. Lastly, the rationale for choosing mRNAs that are downregulated during learning is a bit unclear. Why not look at mRNAs upregulated under control conditions?*

We agree that the resolution of confocal microscopy is a concern. The transcripts we chose are present in the local cell bodies and potentially in local dendrites, so even if we were to find substantial colocalization with MAP2 that would not preclude axonal localization. By EM, the smallest axon diameters are about 100 nm. The EM preparations we have used here represent at least 20% tissue shrinkage, and substantial loss of extracellular space. In our experience with EM work in different preparations, under less harsh processing tissue components are larger and less tightly packed, and the XY resolution of confocal is sufficient to co-localize labels in axons. The Z resolution remains problematic, though. We have performed a new experiment on gently fixed, resin-embedded samples sectioned at 100 nm. In this preparation we were able to see an oligo(dT) probe co-localized with smi312, further indicating the presence of poly-A mRNA in axons.

Our reasoning in choosing those particular transcripts was that transcripts upregulated by learning are likely part of a complex gene expression cascade and their translation levels may fluctuate during consolidation. Downregulated genes may be more likely to be constitutively translated under control conditions.

> 4\) How specific are eukaryotic initiation factor antibodies? To strengthen the authors\' claim for axonal translation machinery it is important to report the extent of labeling for another marker such as a ribosomal protein.

We agree that antibody specificity is very important. The usual control for antibody specificity, acute removal of the antigen from the tissue such as by conditional genetic knockout, is not available for such essential target molecules. Because we could not remove, for instance, eIF4E from the tissue to confirm that the axonal labelling was not an artifact, we immunolabeled several other translation factors, as well as a ribosomal protein (rpS6). We observed axonal labelling of all of these factors/proteins

> 5\) There seems to be a disconnect between presynaptic LTP that is supposedly induced by training and the reduction of synaptic transcripts. How do the authors explain that synapses are strengthened while synaptic proteins (e.g. Rab3A, others) are downregulated?

Our data reflect the levels of ribosome-bound transcripts, not protein or dormant transcripts. One interpretation of our data is that the loss of ribosome-bound transcripts is due to translation and thus accumulation of the protein (and degradation of the transcript).

> Reviewer \#3:
>
> This manuscript investigates the question of whether translation in the presynaptic compartment in the mammalian cortex is altered by learning. The authors provide immuno EM evidence that axons in the rat amygdala contain translation-associated machinery and use TRAP and RNASeq to characterise the ribosome-bound mRNAs in cortical axons projecting to the amygdala under different learning paradigms. They report that over 1200 mRNAs are regulated during the consolidation of associative memory. Mitochondrial and translation related genes, particularly, were upregulated whereas other genes such as synaptic, cytoskeletal and myelin-related, were downregulated. Also, of interest, opposite up/down gene regulation occurred in the cortex. The authors conclude that learning-regulated translation changes occur in axons of the forebrain and suggest that they may be widespread and important for learning.
>
> *This is an interesting study that reports novel findings. Previous work has taken a genome-wide approach to investigating the presynaptic translatome during learning but this has not been done for the presynaptic compartment. Indeed, axonal translation has historically been a controversial area and, although it is now broadly accepted, the important question of whether there are presynaptic changes in local translation associated with plasticity and learning in adult axons has not been investigated. The evidence presented in the manuscript is compelling and the data analysis is careful and thorough. The manuscript is written clearly and well and care is taken to give the background and rationale. Overall, this is an excellent study that adds strong* in vivo evidence that local translation occurs in adult CNS axons and, further, suggests a potentially important functional role during learning. In addition, the RNASeq datasets will serve as an important resource for learning-regulated axonal translation. I have a few comments (see below) that may help improve the manuscript.
>
> 1\) An unexpected and interesting finding in this study is the opposite learning effects in the axonal translatome and the cortex translatome. Although the authors suggest the possibility that compartment-specific translation is coordinated within the cell, the interpretation of this finding is not straightforward because it is not clear what the cortex translatome represents. It would be useful to see an estimate from previous literature or from additional experiments (e.g. staining for markers) indicating which types of cells express the tagged ribosome in the cortex sample and whether the neurons projecting axons to the amygdala are predominant among them.

Unfortunately, none of our viral TRAP reagent remains after our experiments so we are unable to repeat the transfections to double stain for markers. Lentivirus has been shown to be selective for excitatory neurons, however, and we have added a reference to this.

> 2\) In terms of the filtering method, it is confusing to use the words \"axonal translatome\" for the gene set that consists of two differently filtered groups: 1) the genes enriched in the axons versus the cortex and 2) those changed by the training. Their filtering excludes a lot of axonally translated genes whose translation levels are not changed by the training and not significantly higher than the translation in the cortex. Why don\'t the authors filter genes simply by TRAPed vs input (transcriptome) or by TRAPed vs YFP control in the basal (untrained) condition? In this context, the statement that \"The majority of genes in the translatome (75%) were regulated by learning\" is misleading as these regulated genes were enriched by the filtering.

We took the most stringent approach we could think of to define our "axonal translatome," which we agree almost certainly excludes many transcripts that actually are in axons. Because of the lack of consensus on what to expect in an axonal translatome and the longstanding dogma that it should not exist, we chose to focus on transcripts that we had the highest confidence were truly axonal.

We did not do a direct DGE analysis between our TRAP and YFP data for two reasons: First, the TRAP and YFP experiments were not conducted together as a single batch. Between the need to pool animals for TRAP-seq and our rigorous tissue collection approach, we were only able to collect samples from one set of trained and control animals per experiment. Second, we cannot exclude the possibility that eYFP itself binds RNA to some extent, and we did in fact find some mRNAs enriched in our YFP pulldowns versus the tissue transcriptome. Because the YFP was in the transfected TE3 cells and their axons, YFP pulldowns might enrich for mRNA from these cells and potentially result in false negatives depending on the fraction of a given transcript that is ribosome-bound in the axons.

\[Editors' note: this article was subsequently rejected after discussions between the reviewers, but the authors were invited to resubmit.\]

> The reviewers still feel the work has merit and if you feel that you can address the concerns with additional data, we will consider it as a new submission. However you may wish to transfer or submit to another journal. eLfe feels strongly that authors should not do extensive new work if they do not agree with the reviewers. So if you agree, we would be happy to see the manuscript back. If you disagree, we would strongly urge you to submit elsewhere.
>
> Reviewer \#2:
>
> The authors have addressed some of my concerns but important issues remain unresolved.
>
> I still think that better control experiments are required in order to claim that learning regulates the axonal translatome. To my suggestion of testing unpaired CS+US, the authors responded this protocol triggers a different form of learning which is associated with mechanistically unknown forms of synaptic plasticity. Because changes in the translatome can occur by neuronal activity triggered by CS (or US), not necessarily learning, naïve animals are not a proper control. At present, the authors\' findings cannot distinguish between learning and neuronal activity induced by CS or US. Unless the authors use proper controls (e.g. CS or US, other protocol that include similar neuronal activity that paired CS+US) and unequivocally demonstrate that learning, but not neuronal activity alone, is sufficient to change the presynaptic translatome, they should remove learning as a trigger of the observed changes in the translatome. Learning-induced regulation of the translatome is presumably the most novel component of this study and therefore, much more convincing evidence is required.

We respectfully disagree with the reviewer on the appropriate control for this experiment, to which we gave much consideration. First, it should be noted that the rats were not naïve because they were handled and placed in the conditioning box during habituation as well as during training for the same duration as the learning group. As we previously stated and as the reviewer agrees, exposing the animals to the tone-alone or shock-alone would be manifest as novel sensory experiences and likely engage neuronal populations within the amygdala, especially in the case of an innately aversive US. The reviewer is correct in that if we had used tone-alone, shock-alone, or unpaired, we could say that any differences in translation we observed were due to threat conditioning and captured the tone-shock contingency. What we can say is that one group of rats experienced some kind of learning (whether the CS, US, or the CS+US association) and the other group sat in a familiar environment and learned nothing new. We intentionally used "learning" in the title of the manuscript because we felt using the term "threat conditioning" might be misleading, as the reviewer noted. We also used the term training throughout the manuscript to describe precisely what was triggering the changes we observed. If the reviewer feels strongly that we should not use the term learning in the title, we would be willing to change it to something mutually agreeable.

> The authors acknowledged that eIF antibodies may not be that specific. They explain that these essential factors cannot be genetically removed and therefore, the antibody specificity cannot be validated. This is precisely why I requested they should use a different antibody, e.g. against a ribosomal protein. The authors responded they immunolabled the ribosomal protein S6 and even observed axonal labelling with \"all these factors/proteins\". However, no immunoEM image labelling presynaptic/axonal rpS6 is provided.

We actually had presented an immunoEM image of rpS6 labelling in both the original and revised manuscript in Figure 1F. We apologize for not pointing this out more clearly in our previous response to the reviewer's comment.

> To my request that Figure 2 should include widefield immunolabeling of YFP in lateral amygdala, the authors responded their \"entire stock of virus was used\" and that they \"are unable to generate a new batch of tissue for this purpose\". I am not persuaded by this response.

In our previous response, we neglected to say that we did not observe clear eYFP in the lateral amygdala by widefield imaging before we processed our samples for immunoEM, which permitted us to unambiguously observe eYFP immunolabeling in the axons. We now state this clearly in the revised manuscript.

> New results reported in Figure 6 are interesting but must include some quantification -e.g. extent of background labeling v. real signal. All the reader sees is some colocalization examples using poly-A RNA rather than individual mRNAs. The difference between the commercial FISH system and the \"traditional FISH protocol\" is not obvious and should be better clarified in the text. Lastly, the calibration bar in Figure 6 is wrong (5 μm but not 5 nm).

We now included quantification for Figure 6. We also have clarified the difference between the commercial FISH system and traditional FISH protocol. We also have corrected the calibration bar in Figure 6. We thank the reviewer for catching this error.

> Reviewer \#3:
>
> Although I still generally support the publication of this manuscript, I found the authors\' responses to my comments disappointing.

We are pleased that the reviewer supports publication and apologize for the way we responded to the previous critique of the manuscript.

> Their answer to point 1 is cursory and, except for adding a reference indicating that the lentivirus is selective for excitatory neurons, they do not attempt to clarify further what the cortex translatome represents.

We did not intend for our answer to be cursory and should have been more clear in our previous response. We do say: "Although we refer to these samples as cortex and axons, the cortex samples also contain proximal axon segments, myelinated segments that pass through the dorsal portion of the external capsule, as well as intrinsic projections and corticocortical projections terminating in the adjacent areas of TE1 and perirhinal cortex."

> To point 2, they do not appear to have tried to address the comment that their statement \"The majority of genes in the translatome (75%) were regulated by learning\" is misleading as these regulated genes were enriched by the filtering. The text remains basically the same (\"The majority of genes in the translatome (1647 of 2185 or 75%) were regulated by learning\" without a qualification or modification.

We apologize for the lack of clarity in our previous response. We state in the text: "It is important to note that although we are using the term "translatome" to refer to the strangely selected subset of genes we used for analysis, the actual population of axonal mRNAs is almost certainly larger."

We understand that the reviewer disagrees with our filtering of the results, but we do demonstrate in Figure 3---figure supplement 3A that the filtering did not bias the analysis we present. The filtering step is why we have confidence in the set of transcripts that were analyzed. We removed every source of experimental background that we could and we openly state that we are sure that there are false negatives. All of the raw data and analysis are publicly available, so the unfiltered lists are available to anyone who wants to analyze them and use a less conservative definition of the term "axonal". As we now discuss, the mRNAs isolated from axons overexpressing eYFP are likely enriched in axonal transcripts without bias for ribosome binding, and may themselves be of interest.

> To the point about clarifying their use of the term the \'translatome\', the authors need to be more explicit about the fact that they are looking only at ribosome-bound mRNAs and acknowledge that they have not tested the true percentage of mRNAs being translated as they have not performed standard methods to look at this (ribosome foot-printing or ribosome run-off). This distinction is important in the field and should be included for accuracy. It is not sufficient to dismiss it by saying it is \'unwieldy\' to use a more accurate term. They simply need to accurately define their use of the term \'translatome\' here and acknowledge that they do not know what fraction of their ribosome-bound mRNAs are being translated, if any.

We agree with the reviewer. We again apologize for our response and for not being more explicit about the use of the term "translatome". The reviewer is correct that using TRAP we cannot know whether the ribosomes on a given mRNA are in the process of active elongation at the moment of tissue harvest, whether they are in a stalled state undergoing transport, or whether they are awaiting reactivation of elongation. Because the TRAP method does not capture mRNAs that are not ribosome-bound, it excludes any masked mRNAs and therefore TRAPed mRNAs do not represent an axonal transcriptome. We have softened the language in the Introduction, and expanded the Discussion to explicitly address what our data represent in the context of translation regulation.

> Related to this point is the troubling statement in the rebuttal that eYFP itself binds to mRNA to some extent. If this is the case then it seems all the more important to compare TRAP vs YFP. Since they are not using a knock-in RP model, it also raises the question of whether the exogenously expressed eYFP-Rpl10a actually incorporates into ribosomes in their system. It is possible that the mRNA changes they detect with YFP-pulldown reflect mRNAs binding to extraribosomal YFP-Rpl10a and do not, in fact, report translation. Some serious consideration of this point should be included.

We understand the reviewer's concern. We acknowledge that with TRAP some RNAs will bind, whether it's specific or non-specific, to the eYFP tag, just as some RNAs will bind to the HA tag with ribo-tag. Even if RNA does bind to eYFP in the amygdala, under our experimental conditions it is still axonal. We also have added text stating that the YFP pulldown could reflect mRNAs binding extraribosomal eYFP-Rpl10a. However, it should be noted and as expected, that very few genes showed learning-induced changes in the eYFP data set (Figure 3---figure supplement 2), and this data set showed no meaningful functional enrichment and no functional overlap with the TRAPed set (Figure 3---figure supplement 2).

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

> Reviewer \#1:
>
> The authors have answered my recent comments in a satisfactory way. They should be commended on an excellent piece of work that will have a significant impact in the fields of learning and axonal translation.

We are pleased that the reviewer finds the work of value to the field.

> Reviewer \#2:

*The authors have addressed some of my concerns and the manuscript has improved, but key weaknesses remain. Although the word learning comes up 47 times in the text, the experimental evidence that learning -rather than neuronal activity- regulates the axonal translatome remains extremely weak. The authors point that \"one group of rats experienced some kind of learning\" is well-taken, however it does not justify the use of the phrases like \"learning-regulated\", which is found ubiquitously throughout the text. As I have mentioned before, the authors cannot distinguish between translatome changes that result from associative learning v. changes resulting from the foot shock or tone. Therefore, the most that they can reasonably claim is that* in vivo *neuronal activity (driven by specific learning paradigms) results in changes in the axonal translatome.*

As we've noted, we gave very careful consideration to the choice of training and control protocols before beginning the project, and we have added a paragraph to the discussion explaining how the choice was made. The reviewer is correct that our experimental design does not isolate the effects of excitatory associative learning between the tone and the shock, nor was it intended to. The reviewer's concern, as we understand it, is that our results could be induced by neural activity downstream of the hair cell and nociceptor stimulation delivered by the tone and shock, as opposed to the concomitant learning. All other things being equal, learning can be no more easily separated from that neural activity than the activity can be separated from activation of the peripheral mechanoreceptors. This makes the choice of controls a complex one.

The training protocol that we used -- paired tones and shocks given in a familiar context to animals naïve to the stimuli -- induces strong excitatory associative learning. The excitatory association is often controlled for by presenting explicitly unpaired tones and shocks, which produces inhibitory associative learning to the tone and excitatory associative learning to the training context. Novel tones alone produce latent inhibition, a form of non-associative learning, along with remapping of auditory receptive fields and decreased neural responses to the tone. Well habituated tones can be presented without inducing additional learning, but the same degree of habituation would need to be given to all subjects and the resulting latent inhibition would impair learning in the trained group. Novel shocks produce associative learning to the stimulus with the strongest predictive value. Shocks given in a previously trained protocol produce conditioned analgesia, in which the nociceptive processing is dampened within the learning circuit. Prior shocks in a context also produce blocking, the inhibition of new associative learning in the presence of a previously learned predictor. All of these phenomena are extensively documented in decades of literature and are covered in standard behavioral textbooks, we have repeatedly observed all of them in our own experiments, and we have no reason to doubt that they represent genuine concerns.

In essence, our options were to compare different types of learning to each other (different associations or associative vs. non-associative), associative learning in a naïve subject to stimulus exposure in a habituated subject, or learning in a familiar context to exposure to a familiar context. We chose the last. Under ideal circumstances we would have run multiple control groups, even with the expense involved. However, our tissue collections were labor-intensive and timed to the minute, and to further avoid artifact and variability we collected samples from the same cohort of rats within a limited period of the light cycle. After pooling samples for sequencing, there was no practical way to run more than two experimental groups without sacrificing rigor in other aspects. If we were measuring a phenomenon whose normal parameters were well understood -- neuronal membrane properties or dendritic spine density, for example -- it would be an easy choice to isolate one type of learning. Having no a priori expectation of the nature of an adult axonal translatome, we chose the broader comparison of learning versus an experience of relatively low salience. This allowed us to answer simpler questions regarding the basic composition of the axonal translatome and whether it is subject to regulation by experience-induced plasticity (i.e. learning). We have avoided claiming that the effects we observed were specific to excitatory associative learning, and our use of the term "learning" refers collectively to the various changes in information processing that are the result of stimulus presentations.

> The fact that the authors do not observe eYFP labeling in the lateral amygdala is a bit concerning, presumably with confocal microscopy axons in the TE containing eYFP should be visible. That the authors do see eYFP labeling in axons with EM is encouraging, however it does not provide any index of the extent of the overexpression of RPL10a-eYFP construct. How much expression is needed to get sufficient mRNA? Is the amount of RPL10A-eYFP in axons consistent with the EM showing a few polyribosomes or does overexpression drive more RPL10A into the axons than is normal? Moreover, the authors do not report the amount of mRNA that was isolated, therefore it is hard to know whether the RNA isolated is of sufficient quality and quantity for subsequent RNAseq analysis.

We did not find it particularly surprising that eYFP was not visible by light microscopy in axons. Although it was easily visible in the transfected cell bodies, where RPL10a is presumably more concentrated on rough ER, we would not necessarily expect a strong fluorescence signal to be generated from RPL10a-eYFP in axons, where the enveloping myelin, vesicle pools, and white matter can interfere with both excitation and emission of photons, especially if the molecules are not present in high concentrations. We focused on EM imaging because it is more sensitive and can unambiguously localize signal in compartments such as axons.

As we now explain in the Discussion, translation is regulated upstream of ribosome recruitment, so there is no reason to expect that translation would be significantly altered by the presence of excess ribosomal proteins. In addition, the function of overexpressed RPL10a-eYFP was evaluated by Heiman et al. in the initial report of the TRAP technique and found to be equivalent to the endogenous protein. We have clarified in the text that the scarcity of polyribosomes in LA axons is consistent with reports of translation without polyribosomes in other types of axons, and likely reflects alternate translational structures such as monosomes. All final mRNA yields and quality control measures are given in Supplementary File 1. RNA was quantified after amplification, since the raw yield after the IP step is a function of the number of cells infected by the virus, the number of infected cells that project axons to the amygdala, and the amount of white matter collected during the dissection.

[^1]: These authors contributed equally to this work.
